10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the quarterly period ended September 30, 2011

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from   

to

 Commission file number 001-31922

TEMPUR-PEDIC INTERNATIONAL INC.

(Exact name of registrant as specified in its charter)

Delaware	33-1022198
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

 1713 Jaggie Fox Way

Lexington, Kentucky 40511

(Address, including zip code, of principal executive offices)

Registrant’s telephone number, including area code: (800) 878-8889

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  

                Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  x Yes     No

     Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer x  Accelerated filer o      Non-accelerated filer o  (Do not check if a smaller reporting company)  Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.): Yes ¨  No x

The number of shares outstanding of the registrant’s common stock as of October 24, 2011 was 65,930,898 shares. 

TABLE OF CONTENTS

			Page
Special Note Regarding Forward-Looking Statements			3
PART I. FINANCIAL INFORMATION
ITEM 1.	Financial Statements
	Condensed Consolidated Statements of Income		4
	Condensed Consolidated Balance Sheets		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to Condensed Consolidated Financial Statements		7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		23
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk		34
ITEM 4.	Controls and Procedures		35
PART II. OTHER INFORMATION
ITEM 1.	Legal Proceedings		35
ITEM 1A.	Risk Factors		36
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds		36
ITEM 3.	Defaults upon Senior Securities	37
ITEM 5.	Other Information	37
ITEM 6.	Exhibits	37
Signatures		38

2

Special Note Regarding Forward-Looking Statements

     This quarterly report on Form 10-Q, including the information incorporated by reference herein, contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which includes information concerning our plans; objectives; goals; strategies; future events; future revenues or performance; the impact of the macroeconomic environment in both the U.S. and internationally on sales and our business segments; strategic long-term investments; changes in capital expenditures; the impact of consumer confidence; litigation and similar issues; pending tax assessments; financial flexibility; the impact of initiatives to accelerate growth, expand market share and attract sales from the standard mattress market; the improvements in our Net sales; efforts to expand business within established accounts, improve account productivity, reduce costs and operating expenses and improve manufacturing productivity;  initiatives to improve gross margin; the vertical integration of our business; the development, rollout and market acceptance of new products; our ability to further invest in the business and in brand awareness; our ability to meet financial obligations and continue to comply with the terms of our credit facility, including its financial ratio covenants; effects of changes in foreign exchange rates on our reported earnings; our expected sources of cash flow; our ability to effectively manage cash; our ability to align costs with sales expectations; and other information that is not historical information. Many of these statements appear, in particular, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in ITEM 2 of Part I of this report. When used in this report, the words “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon our current expectations and various assumptions. There can be no assurance that we will realize our expectations or that our beliefs will prove correct.

     There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in this report. Important factors that could cause our actual results to differ materially from those expressed as forward-looking statements are set forth in this report, including under the heading “Risk Factors” under ITEM IA of Part II of this report and under the heading “Risk Factors” under ITEM 1A of Part 1 of our Annual Report on Form 10-K for the year ending December 31, 2010. There may be other factors that may cause our actual results to differ materially from the forward-looking statements.

     All forward-looking statements attributable to us apply only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in this report. Except as may be required by law, we undertake no obligation to publicly update or revise any of the forward-looking statements, whether as a result of new information, future events, or otherwise.

     When used in this report, except as specifically noted otherwise, the term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the terms “Company,” “we,” “our,” “ours” and “us” refer to Tempur-Pedic International Inc. and its consolidated subsidiaries.

3

PART 1. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per common share amounts)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2011			2010			2011			2010
Net sales	$	383,085		$	295,785		$	1,051,135		$	812,718
Cost of sales		182,491			145,031			499,213			409,114
Gross profit		200,594			150,754			551,922			403,604
Selling and marketing expenses		72,439			53,215			204,789			146,273
General, administrative and other expenses		31,548			29,385			92,416			83,037
Operating income		96,607			68,154			254,717			174,294
Other expense, net:
Interest expense, net		(3,265	)		(4,068	)		(8,450	)		(11,043	)
Other expense, net		(229	)		(564	)		(950	)		(569	)
Total other expense		(3,494	)		(4,632	)		(9,400	)		(11,612	)
Income before income taxes		93,113			63,522			245,317			162,682
Income tax provision		31,164			19,324			82,024			51,830
Net income	$	61,949		$	44,198		$	163,293		$	110,852
Earnings per common share:
Basic	$	0.93		$	0.64		$	2.41		$	1.56
Diluted	$	0.90		$	0.62		$	2.34		$	1.51
Weighted average common shares outstanding:
Basic		66,655			69,199			67,722			71,065
Diluted		68,571			71,433			69,847			73,450

See accompanying Notes to Condensed Consolidated Financial Statements. 

4

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

	September 30, 2011		December 31, 2010
	(Unaudited)
ASSETS
Current Assets:
Cash and cash equivalents	$	103,015	$	53,623
Accounts receivable, net		151,419		115,630
Inventories		91,046		69,856
Prepaid expenses and other current assets		23,456		18,646
Deferred income taxes		11,522		13,725
Total Current Assets		380,458		271,480
Property, plant and equipment, net		158,567		159,807
Goodwill		212,768		212,468
Other intangible assets, net		67,715		68,745
Other non-current assets		9,128		3,503
Total Assets	$	828,636	$	716,003
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	70,411	$	48,288
Accrued expenses and other current liabilities		89,456		85,469
Income taxes payable		26,173		12,477
Total Current Liabilities		186,040		146,234
Long-term debt		508,500		407,000
Deferred income taxes		29,368		32,315
Other non-current  liabilities		5,291		4,421
Total Liabilities		729,199		589,970
Commitments and contingencies—see Note 9
Total Stockholders’ Equity		99,437		126,033
Total Liabilities and Stockholders’ Equity	$	828,636	$	716,003

See accompanying Notes to Condensed Consolidated Financial Statements. 

5

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine months Ended September 30,
	2011			2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	163,293		$	110,852
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		25,340			23,870
Amortization of stock-based compensation		11,135			7,953
Amortization of deferred financing costs		689			517
Bad debt expense		1,285			2,072
Deferred income taxes		(480	)		2,604
Foreign currency adjustments and other		911			(423	)
Changes in operating assets and liabilities		(23,194	)		(7,731	)
Net cash provided by operating activities		178,979			139,714
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of business, net of cash acquired		(4,566	)		(18,692	)
Acquisition of trademarks and other		(1,980	)		(152	)
Purchases of property, plant and equipment		(18,841	)		(12,330	)
Net cash used by investing activities		(25,387	)		(31,174	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from long-term revolving credit facility		682,000			289,336
Repayments of long-term revolving credit facility		(580,500	)		(149,313	)
Payments of deferred finance costs		(6,192	)		—
Proceeds from issuance of common stock		24,419			22,015
Excess tax benefit from stock based compensation		17,956			3,282
Treasury shares repurchased		(240,000	)		(250,000	)
Net cash used by financing activities		(102,317	)		(84,680	)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS		(1,883	)		146
Increase in cash and cash equivalents		49,392			24,006
CASH AND CASH EQUIVALENTS, beginning of period		53,623			14,042
CASH AND CASH EQUIVALENTS, end of period	$	103,015		$	38,048
Supplemental cash flow information:
Cash paid during the period for:
Interest	$	7,939		$	10,008
Income taxes, net of refunds	$	49,266		$	38,967

See accompanying Notes to Condensed Consolidated Financial Statements.

6

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

(In thousands, except per common share amounts)

(1) Summary of Significant Accounting Policies

(a) Basis of Presentation and Description of Business. Tempur-Pedic International Inc., a Delaware corporation, together with its subsidiaries is a U.S. based, multinational company. The term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the term “Company” refers to Tempur-Pedic International Inc. and its consolidated subsidiaries.

The Company manufactures, markets and sells products including pillows, mattresses and other related products. The Company manufactures essentially all its pressure-relieving TEMPUR® products at three manufacturing facilities, with one located in Denmark and two in the U.S. The Company has sales distribution subsidiaries operating in North America, Europe and Asia Pacific and has third party distribution arrangements in certain other countries where it does not have subsidiaries. The Company sells its products through four sales channels: Retail, Direct, Healthcare and Third party.

                The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States (U.S. GAAP) for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements of the Company and related footnotes for the year ended December 31, 2010, included in the Company’s Annual Report on Form 10-K.

                The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein.

(b) Reclassifications. Certain prior period amounts have been reclassified to conform to the 2011 presentation of Condensed Consolidated Financial Statements, including a reclassification between current Deferred income tax assets and Prepaid expenses and other current assets. Additionally, during the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Income attributable to the noncontrolling interest was not material in 2010 and is presented within Other expense, net in the Condensed Consolidated Statements of Income. These changes do not materially impact previously reported subtotals within the Condensed Consolidated Financial Statements for any previous period presented.

(c) Basis of Consolidation. The accompanying Condensed Consolidated Financial Statements include the accounts of Tempur-Pedic International and its subsidiaries. All subsidiaries are wholly-owned. During the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Intercompany balances and transactions have been eliminated.

(d) Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s results are affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies and changes in the prices of raw materials, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.

7

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

(e) Inventories. Inventories are stated at the lower of cost or market, determined by the first-in, first-out method, and consist of the following:

	September 30, 2011		December 31, 2010
Finished goods	$	66,354	$	53,362
Work-in-process		9,603		5,549
Raw materials and supplies		15,089		10,945
	$	91,046	$	69,856

    (f)Accrued Sales Returns. The Company allows product returns up to 120 days following a sale through certain sales channels and on certain products. Estimated sales returns are provided at the time of sale based on historical sales channel return rates. The level of sales returns differs by channel with the Direct channel typically experiencing the highest rate of return.  Estimated future obligations related to these products are provided by a reduction of sales in the period in which the revenue is recognized. Accrued sales returns are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for sales returns from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,402
Amounts accrued		36,979
Returns charged to accrual		(36,456	)
Balance as of September 30, 2011	$	4,925

                (g) Warranties. The Company provides a 20-year warranty for North American sales and a 15-year warranty for International sales on mattresses, each prorated for the last 10 years. The Company also provides a 2-year to 3-year warranty on pillows. Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized. Estimates of warranty expenses are based primarily on historical claim experience and product testing. Warranties are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for warranties from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,081
Amounts accrued		4,012
Warranties charged to accrual		(3,363	)
Balance as of September 30, 2011	$	4,730

                (h) Revenue Recognition. Sales of products are recognized when persuasive evidence of an arrangement exists, products are shipped and title passes to customers and the risks and rewards of ownership are transferred, the sales price is fixed or determinable and collectability is reasonably assured. The Company extends volume discounts to certain customers and reflects these amounts as a reduction of sales. The Company also reports sales net of tax assessed by qualifying governmental authorities. The Company extends credit based on the creditworthiness of its customers. No collateral is required on sales made in the normal course of business.

8

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

The allowance for doubtful accounts is the Company’s best estimate of the amount of probable credit losses in the Company’s existing accounts receivable. The Company regularly reviews the adequacy of its allowance for doubtful accounts. The Company determines the allowance based on historical write-off experience and current economic conditions. It also considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Account balances are charged off against the allowance after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts included in Accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets was $6,740 and $7,437 as of September 30, 2011 and December 31, 2010, respectively.

(i) Advertising Costs. The Company expenses advertising costs as incurred except for production costs and advance payments, which are deferred and expensed when advertisements run for the first time. Direct response advance payments are deferred and are amortized over the life of the program.

(j) Research and Development Expenses. Research and development expenses for new products are expensed as they are incurred and included in General, administrative and other expenses in the accompanying Condensed Consolidated Statements of Income. Research and development costs charged to expense were $2,373 and $1,714 for the three months ended September 30, 2011 and 2010, respectively. For the nine months ended September 30, 2011 and 2010, research and development costs charged to expense were $7,273 and $5,263, respectively.

(k) Subsequent Events. On October 18, 2011, the Company’s Board of Directors approved the purchase of an additional $80,000 of the Company’s common stock under the previously approved July 2011 authorization. After giving effect to this approval, the total amount authorized and available for repurchase of the Company’s common stock under this authorization is $200,010. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under the Company’s credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice.

(2) Goodwill and Other intangible assets

The following summarizes changes to the Company’s Goodwill, by reportable business segment:

	North America			International			Total
Balance as of December 31, 2010	$	108,931		$	103,537		$	212,468
Foreign currency translation adjustments		(912	)		(125	)		(1,037	)
Goodwill resulting from acquisition		—			1,337			1,337
Balance as of September 30, 2011	$	108,019		$	104,749		$	212,768

On July 4, 2011, the Company acquired the business of its third party distributor in South Korea. The Company paid $4,566 in cash to acquire this entity with additional future payments to former owners required based on certain financial and operational targets. Assets acquired include certain Intangible assets, Inventories, Property, plant and equipment, and Prepaids and other current assets, with the remaining consideration allocated to Goodwill.

9

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

The following table summarizes information relating to the Company’s Other intangible assets, net:

		September 30, 2011						December 31, 2010
	Useful	Gross				Net			Gross				Net
	Lives	Carrying		Accumulated		Carrying			Carrying		Accumulated		Carrying
	(Years)	Amount		Amortization		Amount			Amount		Amortization		Amount
Unamortized indefinite life intangible assets:
Trademarks		$	55,000	$	—	$	55,000	$	55,000	$	—	$	55,000
Amortized intangible assets:
Technology	10	$	16,000	$	14,267	$	1,733	$	16,000	$	13,067	$	2,933
Patents & othe trademarks	5-20		12,533		9,030		3,503		12,063		8,575		3,488
Customer database	5		4,815		4,784		31		4,813		4,691		122
Foam formula	10		3,700		3,299		401		3,700		3,022		678
Reacquired rights	3		5,490		2,745		2,745		5,767		1,440		4,327
Customer relationships	5		5,032		730		4,302		2,492		295		2,197
Total		$	102,570	$	34,855	$	67,715	$	99,835	$	31,090	$	68,745

Amortization expense relating to intangible assets for the Company was $1,429 and $1,219 for the three months ended September 30, 2011 and 2010, respectively. For the nine months ended September 30, 2011 and 2010, amortization expense relating to intangible assets was $3,978 and $3,123, respectively. No impairments of goodwill or other intangible assets have adjusted the gross carrying amount of these assets in any historical period.

3) Long-term Debt

(a) Long-term Debt. Long-term debt for the Company consists of the following:

	September 30, 2011		December 31, 2010
Senior Credit Facility:
Domestic Long-Term Revolving Criedit Facility payable to lenders, interest at Base Rate or LIBOR plus applicable margin (1.99% and 1.87% as of
September 30, 2011 and December 31, 2010, respectively), commitment through and due June 28, 2016	$	508,500	$	407,000
Long-term debt	$	508,500	$	407,000

                (b)Secured Credit Financing. On October 18, 2005, the Company entered into a credit agreement (Senior Credit Facility) with a syndicate of banks. On June 28, 2011, the Company amended and restated its Senior Credit Facility, as amended, which increased the total availability under the Senior Credit Facility to an aggregate of $770,000, added an option to increase domestic availability by an additional $250,000, extended the maturity date to June 28, 2016, and increased the applicable margins and certain fees to current market conditions.

10

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

The Senior Credit Facility consists of domestic and foreign credit facilities (Revolvers) that provide for the incurrence of indebtedness up to an aggregate principal amount of $770,000. The domestic credit facility is a five-year, $745,000 revolving credit facility. The foreign credit facility is a five-year, $25,000 revolving credit facility. The Revolvers provide for the issuance of letters of credit and bank guarantees (Contingent Liabilities) which, when issued, constitute usage and reduce availability under the Revolvers. The aggregate amount of Contingent Liabilities outstanding under the Revolvers was $990 at September 30, 2011. After giving effect to Contingent Liabilities and $508,500 in borrowings under the Revolvers, total availability under the Revolvers was $260,510 as of September 30, 2011. Both credit facilities bear interest at a rate equal to the applicable margin, as determined in accordance with a performance pricing grid set forth in the Senior Credit Facility, plus one of the following indexes: London Inter-Bank Offering Rate (LIBOR) and for U.S. dollar-denominated loans only, a base rate. The base rate of U.S. dollar-denominated loans is defined as the higher of the Bank of America prime rate or the Federal Funds rate plus .50%. The Company also pays an annual commitment fee on the unused amount of the Senior Credit Facility.  The commitment fee is calculated based on the consolidated leverage ratio and ranges from .375% to .50%.

The Senior Credit Facility is guaranteed by Tempur-Pedic International, as well as certain other subsidiaries of Tempur-Pedic International, and is secured by certain fixed and intangible assets of Dan-Foam ApS and substantially all the Company’s U.S. assets. The Senior Credit Facility contains certain financial covenants and requirements affecting the Company, including a consolidated interest coverage ratio and a consolidated leverage ratio. The Company was in compliance with all covenants as of September 30, 2011.

In conjunction with the Company amending and restating its Senior Credit Facility, $6,192 of deferred financing costs were capitalized and will be amortized over the five year extension.

On August 8, 2011, the Company entered into a four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates associated with the Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding the Company’s derivative instruments, including this interest rate swap.

(4) Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset and liability in an orderly transaction between market participants at the measurement date. The Company estimates fair value of its financial instruments utilizing an established three-level hierarchy. The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date as follows:

 ● Level 1 – Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.

● Level 2 – Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 ● Level 3 – Valuation is based upon other unobservable inputs that are significant to the fair value measurements.

11

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

                The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement. There were no transfers between levels for the three months ended September 30, 2011. At September 30, 2011, the Company had an interest rate swap and foreign currency forward contracts recorded at fair value.  Estimates of the fair value of foreign currency derivative instruments are determined using exchange traded prices and rates. The fair value of the interest rate swap is calculated using standard industry models based on observable forward yield curves. The fair values of all derivative instruments are adjusted for credit risk and restrictions and other terms specific to the contracts.

The following table provides a summary by level of the fair value of financial instruments that are measured on a recurring basis:

			Fair Value Measurements at September 30, 2011 Using:
	September 30, 2011		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	622	$	—	$	622	$	—
Interest rate swap	$	2,318	$	—	$	2,318	$	—

			Fair Value Measurements at December 31, 2010 Using:
	December 31, 2010		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	676	$	—	$	676	$	—
Interest rate swap	$	1,430	$	—	$	1,430	$	—

The carrying value of Cash and cash equivalents, Accounts receivable and Accounts payable approximate fair value because of the short-term maturity of those instruments. Borrowings under the Senior Credit Facility (as defined in Note 3(b)) are at variable interest rates and accordingly their carrying amounts approximate fair value.

(5) Derivative Financial Instruments

In the normal course of business, the Company is exposed to certain risks related to fluctuations in interest rates and foreign currency exchange rates. The Company uses various derivative contracts, primarily interest rate swaps and foreign currency exchange forward contracts, to manage risks from these market fluctuations. The financial instruments used by the Company are straight-forward, non-leveraged instruments. The counterparties to these financial instruments are financial institutions with strong credit ratings. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit ratings of these institutions.

12

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

Interest Rate Risk

The Company is exposed to changes in interest rates on its Senior Credit Facility. In order to manage this risk, on August 8, 2011, the Company entered into a four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates. The Company designated this interest rate swap as a cash flow hedge of floating rate borrowings and expects the hedge to be highly effective in offsetting fluctuations in the designated interest payments resulting from changes in the benchmark interest rate. The gains and losses on the designated swap agreement will offset losses and gains on the transactions being hedged. The Company formally documented the effectiveness of this qualifying hedge instrument (both at the inception of the swap and on an ongoing basis) in offsetting changes in cash flows of the hedged transaction. The fair value of the interest rate swap is calculated as described in Note 4, “Fair Value Measurements” taking into consideration current interest rates and the current creditworthiness of the counterparties or the Company, as applicable.

                As a result of this swap, the Company will pay interest at a fixed rate and receive payment at a variable rate beginning on December 30, 2011. The swap effectively fixes the floating LIBOR-based interest rate to 1.25% on $250,000 of the outstanding balance under the 2005 Senior Credit Facility, with the outstanding balance subject to the swap declining over time. The interest rate swap expires on December 30, 2015. The Company will select the LIBOR-based rate on the hedged portion of the Senior Credit Facility during the term of the swap. The effective portion of the change in value of the swap is reflected as a component of comprehensive income and recognized as Interest expense, net as payments are paid or accrued. The remaining gain or loss in excess of the cumulative change in the present value of the future cash flows of the hedged item, if any (i.e., the ineffective portion) or hedge components excluded from the assessment of effectiveness are recognized as Interest expense, net during the current period.

Foreign Currency Exposures

The Company is exposed to foreign currency risk related to intercompany debt and associated interest payments. To manage the risk associated with fluctuations in foreign currencies, the Company enters into foreign currency forward contracts. The Company does not designate any of these foreign currency forward contracts as hedging instruments, however, the Company considers the contracts as economic hedges. Accordingly, changes in the fair value of these instruments affect earnings during the current period. These foreign currency forward contracts protect against the reduction in value of forecasted foreign currency cash flows resulting from payments in foreign currencies. The fair value of foreign currency agreements are estimated as described in Note 4, “Fair Value Measurements” taking into consideration foreign currency rates and the current creditworthinessof the counterparties or the Company, as applicable.

As of September 30, 2011, the Company had foreign currency forward contracts with expiration dates ranging from October 28, 2011 through December 30, 2011. The changes in fair value of these foreign currency hedges are included as a component of Other expense, net. As of September 30, 2011, the Company had the following outstanding foreign currency forward contracts:

Foreign Currency Denomination	Notional Amount
Japanese Yen	¥	340,862
Swedish Krone	kr.	19,135
Norwegian Krone	kr.	7,108
Australian Dollar	$	1,727
New Zealand Dollar	$	1,954
Singapore Dollar	$	403
Canadian Dollar	$	523
United States Dollar	$	9,738

13

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

As of September 30, 2011 and December 31, 2010, the fair value carrying amount of the Company’s derivative instruments included in the accompanying Condensed Consolidated Balance Sheets were recorded as follows:

		Liability Derivatives
		September 30, 2011			December 31, 2010
		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
	Interest rate swap – current	Accrued expenses and other current liabilities	$	1,050	Accrued expenses and other current liabilities	$	1,430
	Interest rate swap – non-current	Other non-current liabilities		1,268			—
			$	2,318		$	1,430
Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Accrued expenses and other current liabilities	$	622	Accrued expenses and other current liabilities	$	676
			$	2,940		$	2,106

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the three months ended September 30, 2011 was as follows:

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,266	)

14

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

For the three months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	1,280	Interest expense, net	$	(1,734	)	Interest expense, net	$	—

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	38

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the nine months ended September 30, 2011 was as follows:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)			Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Loss  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Loss  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	(582	)	Interest expense, net	$	(582	)	Interest expense, net	$	—

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(228	)

15

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

For the nine months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss) Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	4,003	Interest expense, net	$	(5,222	)	Interest expense, net	$	—

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,315	)

(6) Stockholders’ Equity

(a) Capital Stock. Tempur-Pedic International’s authorized shares of capital stock are 300,000 shares of common stock and 10,000 shares of preferred stock. Subject to preferences that may be applicable to any outstanding preferred stock, holders of the common stock are entitled to receive ratably such dividends as may be declared from time to time by the Board of Directors out of funds legally available for that purpose. In the event of liquidation, dissolution or winding up, the holders of the common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding.

(b) Share Repurchase Programs. During the nine months ended September 30, 2011, the Company purchased 4,251 shares of the Company’s common stock for a total of $240,000 pursuant to the authorizations adopted by the Company’s Board of Directors in January and July 2011. During 2010, the Company purchased 8,500 shares of the Company’s common stock for a total cost of $250,000 pursuant to the authorizations made by the Company’s Board of Directors. On July 25, 2011, the Company’s Board of Directors terminated the remaining authority under the January 2011 authorization and approved a new share repurchase authorization of up to $200,000 of the Company’s common stock. As of September 30, 2011, the Company has $120,010 remaining under the July 2011 authorization. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under our credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice. Refer to Note 1(k), “Subsequent Events” for additional information regarding the Company’s increase to the July 2011 authorization on October 18, 2011.

16

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

(7) Other Items

(a) Property, plant and equipment.  Property, plant and equipment, net consisted of the following:

	September 30, 2011			December 31, 2010
Land and buildings	$	122,690		$	121,188
Machinery and equipment, furniture and fixtures and other		225,218			208,310
Construction in progress		9,834			9,858
		357,742			339,356
Accumulated depreciation		(199,175	)		(179,549	)
	$	158,567		$	159,807

(b) Accrued expenses and other current liabilities. Accrued expenses and other current liabilities consisted of the following:

	September 30, 2011		December 31, 2010
Salary and related expenses	$	20,996	$	22,171
Accrued unrecognized tax benefits		12,398		12,035
Advertising accrual		10,443		6,981
Accrued sales and value added taxes		9,881		10,614
Warranty accrual		4,730		4,081
Sales returns		4,925		4,402
Other		26,083		25,185
	$	89,456	$	85,469

(c) Accumulated other comprehensive loss. Accumulated other comprehensive loss consisted of the following:

	September 30, 2011			December 31, 2010
Derivative instruments accounted for as hedges, net of taxes of $904 and $558, respectively	$	(1,414	)	$	(872	)
Foreign currency adjustments		(8,174	)		(5,316	)
Accumulated other comprehensive loss	$	(9,588	)	$	(6,188	)

(d) Comprehensive income. The components of comprehensive income consisted of the following:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011			2010
Net income	$	61,949		$	44,198	$	163,293		$	110,852
Derivative instruments accounted for as hedges, net of taxes of $904, $499, $346 and $1,561,        respectively		(1,414	)		781		(542	)		2,442
Foreign currency adjustments		(14,344	)		11,744		(2,858	)		(1,472	)
Total comprehensive income	$	46,191		$	56,723	$	159,893		$	111,822

17

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

(8) Stock-Based Compensation

The Company currently has three stock-based compensation plans: the 2002 Option Plan (2002 Plan), the Amended and Restated 2003 Equity Incentive Plan (2003 Plan) and the 2003 Employee Stock Purchase Plan (ESPP), which are described under the caption “Stock-based Compensation” in the Notes to the Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. Effective February 1, 2010, the Company suspended offerings under the ESPP indefinitely.

In the first quarter of 2010, the Compensation Committee of the Board of Directors approved the terms of a Long-Term Incentive Program (LTIP), established under the 2003 Plan. The LTIP awards consist of a mix of stock options and performance-based restricted stock units (PRSUs). Shares with respect to the PRSUs will be granted, if they vest, following the end of the applicable performance period and achievement of applicable performance metrics as determined by the Compensation Committee of the Board of Directors.

The Company granted PRSUs during the nine months ended September 30, 2011. The maximum number of shares to be awarded under the PRSUs granted during the nine months ended September 30, 2011 will be 443 shares,  and will vest, if earned, at the end of the three-year performance period ending on December 31, 2013. No PRSUs were granted during the three months ended September 30, 2011.  Actual payout under the PRSUs granted is dependent upon the achievement of certain financial goals, based on Net sales and Earnings Before Interest and Taxes (EBIT) margin targets. Based on current estimates of the performance metrics, unrecognized compensation expense with respect to the PRSUs granted in 2011 was $5,401 as of September 30, 2011, which is expected to be recorded over the weighted average remaining life of 2.25 years. The maximum number of shares to be awarded under the PRSUs granted during the nine months ended September 30, 2010 will be 418. No PRSUs were granted during the three months ended September 30, 2010. The Company recorded $1,708 and $359 of compensation expense associated with PRSUs for the three months ended September 30, 2011 and 2010, respectively. The Company recorded $5,719 and $822 of compensation expense associated with PRSUs for the nine months ended September 30, 2011 and 2010, respectively.

The Company granted options to purchase 2 and 85 shares of common stock during the three and nine months ending September 30, 2011, respectively. The Company granted options to purchase 30 and 192 shares of common stock during the three and nine months ending September 30, 2010, respectively. The Company recorded $1,237 and $1,720 of compensation expense associated with options for the three months ended September 30, 2011 and September 30, 2010, respectively. The Company recorded $3,931 and $5,892 of compensation expense associated with options for the nine months ended September 30, 2011 and 2010, respectively. As of September 30, 2011, there was $1,609 of unrecognized compensation expense associated with the options granted in 2011, which is expected to be recorded over the weighted average remaining vesting period of 2.27 years. The options granted in the three months ended September 30, 2011 had a weighted average grant-date fair value of $32.53 per option, as determined by the Black-Scholes option pricing model using the following assumptions:

Expected volatility of stock	73.34	%
Expected life of options, in years	4.0
Risk-free interest rate	0.66	%
Expected dividend yield on stock	0.0	%

The Company granted 9 deferred stock unit (DSU) awards during nine months ended September 30, 2011. The Company granted 188 awards during the nine months ended September 30, 2010 that consisted of restricted stock units (RSUs) and DSUs. No RSUs or DSUs were granted during the three months ended September 30, 2011 or 2010.  As of September 30, 2011, there was $340 of unrecognized compensation expense associated with the DSUs granted in 2011, which is expected to be recorded over the weighted average remaining vesting period of 0.57 years. The Company recorded $471 and $535 of compensation expense associated with RSUs and DSUs for the three months ended September 30, 2011 and September 30, 2010. The Company recorded $1,485 and $1,224 of compensation expense associated with RSUs and DSUs for the nine months ended September 30, 2011 and 2010, respectively.

                The Company recorded $3,416 and $2,614 of total stock-based compensation expense for the three months ended September 30, 2011 and 2010, respectively. The Company recorded $11,135 and $7,953 of total stock-based compensation expense for the nine months ended September 30, 2011 and 2010, respectively.

18

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

(9) Commitments and Contingencies

(a)Purchase Commitments. The Company enters into limited purchase commitments for the purchase of certain raw materials. Amounts committed under these programs were not significant as of September 30, 2011 or December 31, 2010.

(b) Antitrust Action. On January 5, 2007, a purported class action was filed against the Company in the United States District Court for the Northern District of Georgia, Rome Division (Jacobs v. Tempur-Pedic International, Inc. and Tempur-Pedic North America, Inc., or the Antitrust Action).  The Antitrust Action alleges violations of federal antitrust law arising from the pricing of Tempur-Pedic mattress products by Tempur-Pedic North America and certain distributors.  The action alleges a class of all purchasers of Tempur-Pedic mattresses in the United States since January 5, 2003, and seeks damages and injunctive relief. Count Two of the complaint was dismissed by the court on June 25, 2007, based on a motion filed by the Company. Following a decision issued by the United States Supreme Court in Leegin Creative Leather Prods., Inc. v. PSKS, Inc. on June 28, 2007, the Company filed a motion to dismiss the remaining two counts of the Antitrust Action on July 10, 2007. On December 11, 2007, that motion was granted and, as a result, judgment was entered in favor of the Company and the plaintiffs’ complaint was dismissed with prejudice. On December 21, 2007, the plaintiffs filed a “Motion to Alter or Amend Judgment,” which was fully briefed. On May 1, 2008, that motion was denied.  Jacobs appealed the dismissal of their claims, and the parties argued the appeal before the United States Circuit Court for the Eleventh Circuit on December 11, 2008.  The Court rendered an opinion favorable to the Company on December 2, 2010, affirming the trial court’s refusal to allow Jacobs to alter or amend its pleadings and dismissing its claims.  Jacobs has subsequently petitioned the 11th Circuit Court of Appeals for an “en banc” review of the three judge panel’s ruling.  The Company continues to strongly believe that the Antitrust Action lacks merit, and intends to defend against the claims vigorously. Based on the findings of the court to date and an assessment of the Company’s meritorious defenses, the Company believes that it is remote that it will incur a loss with respect to this matter. However, due to the inherent uncertainties of litigation, the Company cannot predict the outcome of the Antitrust Action at this time, and can give no assurance that these claims will not have a material adverse affect on the Company’s financial position or results of operations.

(c) New York Attorney General. In December 2008, the Office of the Attorney General of the State of New York, Antitrust Bureau (OAG) requested that the Company consider discontinuing its unilateral retail price policy (UPPL) in the State of New York, and informed the Company that it may bring an enforcement action against the Company under New York law if the Company chose not to do so. On March 29, 2010, the Office of the Attorney General filed suit in New York state court against the Company with respect to this matter. The complaint does not charge the Company with any violation of state or federal antitrust law; instead it claims the Company violated a 1975 New York state law which declares certain contractual provisions to be unenforceable and not actionable at law and seeks, among other things, a permanent injunction prohibiting the Company’s UPPL as well as unspecified sums for restitution and disgorgement of profits. The Company responded to the complaint and also filed motions to dismiss and to obtain discovery. On September 28, 2010, the court heard various motions filed by the parties and took them under advisement. On January 14, 2011, the court denied the OAG’s petition in full and granted the Company’s motion to dismiss. The OAG filed an appeal on February 22, 2011. The Company believes that its UPPL complies with state and federal law and intends to continue to vigorously defend it in this matter. No claim for damages has been received by the Company. Based on the findings of the court to date and an assessment of the Company’s meritorious defenses, the Company believes that it is remote that it will incur a loss with respect to this matter. However, due to the inherent uncertainties of litigation, the Company cannot predict the outcome of this matter at this time, and can give no assurance that these claims will not have a material adverse affect on the Company’s financial position or results of operations.

The Company is involved in various other legal proceedings incidental to the operations of its business. The Company believes that the outcome of all such pending legal proceedings in the aggregate will not have a material adverse affect on its business, financial condition, liquidity, or operating results.

19

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

10) Income Taxes

The Company’s effective tax rate for the three months ended September 30, 2011 and September 30, 2010 was 33.5% and 30.5%, respectively. The Company’s effective tax rate for the nine months ended September 30, 2011 and September 30, 2010 was 33.4% and 31.9%, respectively. The Company’s effective income tax rate for the three and nine months ended September 30, 2011 and 2010 differed from the federal statutory rate of 35.0% principally because of certain foreign tax rate differentials, state and local income taxes, foreign income currently taxable in the U.S., the production activities deduction and certain other permanent differences.

The Company has not provided for U.S. federal and/or state income and foreign withholding taxes on $300,394 of undistributed earnings from non-U.S. operations as of September 30, 2011 because Tempur-Pedic International intends to reinvest such earnings indefinitely outside of the United States.  If these earnings were to be distributed, foreign tax credits may become available under current law to reduce the resulting U.S. income tax liability.

During the fourth quarter of 2007, the Company received an income tax assessment from the Danish Tax Authority with respect to the 2001, 2002 and 2003 tax years, an assessment with respect to the 2004 tax year during the third quarter of 2010, and an assessment with respect to the 2005 tax year during the second quarter of 2011.  The tax assessments relate to the royalty paid by one of Tempur-Pedic International’s U.S. subsidiaries to a Danish subsidiary and the position taken by the Danish Tax Authority could apply to subsequent years. The total tax assessment is approximately $103,050 including interest and penalties.  In the first quarter of 2008 and the third quarter of 2010, the Company filed timely complaints with the Danish National Tax Tribunal denying the tax assessments.  The National Tax Tribunal formally agreed to place the Danish tax litigation on hold pending the outcome of a Bilateral Advance Pricing Agreement (Bilateral APA) between the United States and the Danish Tax Authority.  A Bilateral APA involves an agreement between the Internal Revenue Service (IRS) and the taxpayer, as well as a negotiated agreement with one or more foreign competent authorities under applicable income tax treaties.  During the third quarter of 2008, the Company filed the Bilateral APA with the IRS and the Danish Tax Authority.  U.S. and Danish competent authorities initially met to discuss the Company’s Bilateral APA during the first quarter of 2011 and additional meetings are expected. The Company believes it has meritorious defenses to the proposed adjustments and will oppose the assessments in the Danish courts, as necessary. It is reasonably possible the amount of unrecognized tax benefits may change in the next twelve months.  An estimate of the amount of such change cannot be made at this time.

                The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions.  With few exceptions, the Company is no longer subject to tax examinations by tax authorities in the U.S. for periods prior to 2007, U.S. state and local municipalities for periods prior to 2006, and in non-U.S. jurisdictions for periods prior to 2003. Additionally, the Company is currently under examination by various tax authorities around the world.  The Company anticipates it is reasonably possible an increase or decrease in the amount of unrecognized tax benefits could be made in the next twelve months as a result of the statute of limitations expiring and/or the examinations being concluded on these returns.  However, the Company does not presently anticipate that any increase or decrease in unrecognized tax benefits will be material to the consolidated financial statements. During the three months ended September 30, 2011, there were no significant changes to the liability for unrecognized tax benefits.

20

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

(11) Earnings Per Common Share

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Numerator:
Net income	$	61,949	$	44,198	$	163,293	$	110,852
Denominator:
Denominator for basic earnings per common share-weighted average shares		66,655		69,199		67,722		71,065
Effect of dilutive securities:
Employee stock-based compensation		1,916		2,234		2,125		2,385
Denominator for diluted earnings per common share-adjusted weighted average shares		68,571		71,433		69,847		73,450
Basic earnings per common share	$	0.93	$	0.64	$	2.41	$	1.56
Diluted earnings per common share	$	0.90	$	0.62	$	2.34	$	1.51

The Company excluded 8 and 173 shares issuable upon exercise of outstanding stock options for the three months ended September 30, 2011 and 2010, respectively, and 4 and 120 shares issuable upon exercise of outstanding stock options for the nine month periods ended September 30, 2011 and 2010, respectively, from the Diluted earnings per common share computation because their exercise price was greater than the average market price of Tempur-Pedic International’s common stock or they were otherwise anti-dilutive.

(12) Business Segment Information

The Company operates in two business segments: North America and International. These reportable segments are strategic business units that are managed separately based on the fundamental differences in their operations. The North American segment consists of the two U.S. manufacturing facilities and our North American distribution subsidiaries. The International segment consists of the manufacturing facility in Denmark, whose customers include all of the distribution subsidiaries and third party distributors outside the North American segment. The Company evaluates segment performance based on Net sales and Operating income.

The following table summarizes Total assets by segment:

	September 30, 2011			December 31, 2010
Total assets:
North America	$	674,155		$	576,139
International		409,945			338,685
Intercompany eliminations		(255,464	)		(198,821	)
	$	828,636		$	716,003

21

TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) – (Continued)

(In thousands, except per common share amounts)

The following table summarizes segment information:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Net sales from external customers:
North America
Mattresses	$	192,683	$	150,941	$	527,398	$	405,013
Pillows		19,182		18,307		53,502		46,494
Other		67,462		45,439		174,542		121,955
	$	279,327	$	214,687	$	755,442	$	573,462
International
Mattresses	$	63,122	$	48,224	$	178,361	$	141,841
Pillows		18,937		15,652		54,215		46,136
Other		21,699		17,222		63,117		51,279
	$	103,758	$	81,098	$	295,693	$	239,256
	$	383,085	$	295,785	$	1,051,135	$	812,718
Inter-segment sales:
North America	$	2,465	$	169	$	2,778	$	169
International		864		634		2,092		1,295
Intercompany eliminations		(3,329)		(803)		(4,870)		(1,464)
	$	—	$	—	$	—	$	—
Gross Profit
Domestic	$	139,744	$	101,835	$	375,760	$	263,753
International		60,850		48,919		176,162		139,851
	$	200,594	$	150,754	$	551,922	$	403,604
Operating income:
North America	$	69,390	$	45,498	$	179,789	$	108,622
International		27,217		22,656		74,928		65,672
	$	96,607	$	68,154	$	254,717	$	174,294
Depreciation and amortization (including stock-based compensation amortization):
North America	$	9,255	$	8,545	$	28,516	$	25,148
International		2,911		2,233		7,959		6,675
	$	12,166	$	10,778	$	36,475	$	31,823
Capital expenditures:
North America	$	4,434	$	3,116	$	11,392	$	7,043
International		2,309		2,516		7,449		5,287
	$	6,743	$	5,632	$	18,841	$	12,330

22

 ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the Condensed Consolidated Financial Statements and accompanying notes included in this Form 10-Q. Unless otherwise noted, all of the financial information in this report is condensed consolidated information for the Company. The forward-looking statements in this discussion regarding the mattress and pillow industries, our expectations regarding our future performance, liquidity and capital resources and other non-historical statements in this discussion include numerous risks and uncertainties, as described under “Special Note Regarding Forward-Looking Statements” and “Risk Factors” elsewhere in this quarterly report on Form 10-Q and in our Annual Report on Form 10-K for the year ended December 31, 2010. Our actual results may differ materially from those contained in any forward-looking statements. Except as may be required by law, we undertake no obligation to publicly update or revise any of the forward-looking statements contained herein.

In this discussion and analysis, we discuss and explain the financial condition and results of our operations for the three and nine month periods ended September 30, 2011 and 2010, including the following points:

●  An overview of our business and strategy; 

 ●  Our Net sales and costs in the periods presented as well as changes between periods;

 ●  Expected future expenditures for capital projects and sources of liquidity for future operations; and

 ●  The effect of the foregoing on our overall financial performance and condition, as well as factors that could affect our future performance.

Executive Overview

General. We are the leading manufacturer, marketer and distributor of premium mattresses and pillows which we sell in approximately 80 countries under the TEMPUR® and Tempur-Pedic® brands. We believe our premium mattresses and pillows are more comfortable than standard bedding products because our proprietary pressure-relieving TEMPUR® material is temperature sensitive, has a high density and therapeutically conforms to the body.

We sell our premium mattresses and pillows through four distribution channels: Retail (furniture and bedding, specialty and department stores); Direct (direct response, internet and company-owned stores); Healthcare (chiropractors, medical retailers, hospitals and other healthcare markets); and Third party distributors in countries where we do not sell directly through our own subsidiaries.

In our International segment certain of our subsidiaries sell directly through company-owned stores. Until recently these sales have not been material and were reported through our Retail channel. In 2011, and consistent with our growth initiatives, we are reporting company-owned stores in the International segment within the Direct channel. Prior period amounts have been reclassified to conform to the 2011 presentation of Net sales, by channel and by segment. These changes do not impact previously reported International segment Net sales totals.

Business Segment Information. We have two reportable business segments: North America and International. These reportable segments are strategic business units that are managed separately based on the fundamental differences in their geographies. The North American operating segment consists of two U.S. manufacturing facilities, whose customers include our North American distribution subsidiaries. The International segment consists of our manufacturing facility in Denmark, whose customers include all of our distribution subsidiaries and third party distributors outside the North American segment. We evaluate segment performance based on Net sales and Operating income.

On April 1, 2010, we purchased our Third party distributor in Canada. Accordingly, Net sales in the Canadian market are reported in the appropriate channels within the North American segment. As Canada represented essentially all sales through the North American Third party channel, we no longer report Third party sales in this segment.

23

Strategy and Outlook

Our goal is to become the world’s favorite mattress and pillow brand. In order to achieve this long-term goal while managing through the current economic environment, we expect to continue to pursue certain key strategic goals using the related strategies discussed below.

● Make sure everyone knows that they would sleep better on a Tempur-Pedic - we plan to continue to invest in our global brand awareness through advertising campaigns that further associate our brand name with overall sleep and premium quality products.

 ● Make sure there is a Tempur-Pedic bed and pillow that appeals to everyone - we plan to continue to maintain our focus on premium mattresses and pillows and regularly introduce new products.

 ● Make sure that Tempur-Pedic is available to everyone - we plan to expand our points of distribution and the effectiveness of our distribution channels.

 ● Make sure that Tempur-Pedic continues to deliver the best sleep - we plan to continue to invest in product research and development.

In pursuing these strategic goals, we expect to continue to optimize our cost structure in order to enable these marketing and product development investments.

Results of Operations

Key financial highlights for the three and nine months ended September 30, 2011 include the following:

● Earnings per diluted common share (EPS) were $0.90 for the three months ended September 30, 2011 compared to $0.62 for the three months ended September 30, 2010. For the nine months ended September 30, 2011, EPS were $2.34 compared to $1.51 for the same period in 2010.

 ● Net sales for the three months ended September 30, 2011 increased to $383.1 million from $295.8 million for the same period in 2010. Net sales for the nine months ended September 30, 2011 increased to $1,051.1 million from $812.7 million for the same period in 2010.

 ● Our Gross profit margin in the third quarter of 2011 was 52.4% compared to 51.0% for the third quarter of 2010. For the nine months ended September 30, 2011, our Gross profit margin was 52.5% compared to 49.7% for the same period in 2010.

 ● During the nine months ended September 30, 2011, we generated $179.0 million of operating cash flow compared to $139.7 million for the nine months ended September 30, 2010.

24

(In thousands, except per common share amounts)	Three Months Ended September 30,										Nine Months Ended September 30,
	2011					2010					2011					2010
Net sales	$	383,085		100.0	%	$	295,785		100.0	%	$	1,051,135		100.0	%	$	812,718		100.0	%
Cost of sales		182,491		47.6			145,031		49.0			499,213		47.5			409,114		50.3
Gross profit		200,594		52.4			150,754		51.0			551,922		52.5			403,604		49.7
Selling and marketing expenses		72,439		18.9			53,215		18.0			204,789		19.5			146,273		18.0
General, administrative and other expenses		31,548		8.3			29,385		10.0			92,416		8.8			83,037		10.2
Operating income		96,607		25.2			68,154		23.0			254,717		24.2			174,294		21.5
Interest expense, net		(3,265	)	(0.9	)		(4,068	)	(1.4	)		(8,450	)	(0.8	)		(11,043	)	(1.4	)
Other expense, net		(229	)	(0.0	)		(564	)	(0.1	)		(950	)	(0.1	)		(569	)	(0.1	)
Income before income taxes		93,113		24.3			63,522		21.5			245,317		23.3			162,682		20.0
Income tax provision		31,164		8.1			19,324		6.5			82,024		7.8			51,830		6.4
Net income	$	61,949		16.2	%	$	44,198		15.0	%	$	163,293		15.5	%	$	110,852		13.6	%
Earnings per common share:
Basic	$	0.93				$	0.64				$	2.41				$	1.56
Diluted	$	0.90				$	0.62				$	2.34				$	1.51
Weighted average common shares outstanding:
Basic		66,655					69,199					67,722					71,065
Diluted		68,571					71,433					69,847					73,450

Three Months Ended September 30, 2011 Compared with Three Months Ended September 30, 2010

A summary of Net sales, by channel and by segment, is set forth below:

	CONSOLIDATED				NORTH AMERICA				INTERNATIONAL
	Three Months Ended				Three Months Ended				Three Months Ended
	September 30,				September 30,				September 30,
(in thousands)	2011		2010		2011		2010		2011		2010
Retail	$	342,804	$	260,351	$	257,049	$	197,586	$	85,755	$	62,765
Direct		25,405		18,146		19,588		14,192		5,817		3,954
Healthcare		8,076		8,158		2,690		2,909		5,386		5,249
Third Party		6,800		9,130		—		—		6,800		9,130
	$	383,085	$	295,785	$	279,327	$	214,687	$	103,758	$	81,098

                A summary of Net sales, by product and by segment, is set forth below:

	CONSOLIDATED				NORTH AMERICA				INTERNATIONAL
	Three Months Ended				Three Months Ended				Three Months Ended
	September 30,				September 30,				September 30,
(in thousands)	2011		2010		2011		2010		2011		2010
Mattresses	$	255,805	$	199,165	$	192,683	$	150,941	$	63,122	$	48,224
Pillows		38,119		33,959		19,182		18,307		18,937		15,652
Other		89,161		62,661		67,462		45,439		21,699		17,222
	$	383,085	$	295,785	$	279,327	$	214,687	$	103,758	$	81,098

25

Net sales. Net sales for the three months ended September 30, 2011 increased to $383.1 million from $295.8 million for the same period in 2010, an increase of $87.3 million, or 29.5%. We believe our revenues have continued gaining momentum primarily as a result of investments made in marketing, the success of new product introductions and expanding points of distribution. Consolidated Mattress sales increased $56.6 million, or 28.4%, compared to the third quarter of 2010. The increase in Mattress sales occurred primarily in our Retail channel with Net sales increasing to $342.8 million from $260.4 million for the same period in 2010, an increase of $82.5 million, or 31.7%. Consolidated Pillow sales increased $4.2 million, or 12.3%, compared to the third quarter of 2010. Consolidated Other, which primarily includes adjustable bed bases and foundations, increased $26.5 million, or 42.3%. Many of our Pillows and Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Pillows and Other products are also positively impacted. Direct sales increased $7.3 million, or 40.0% from the same period in 2010.The principal factors that impacted Net sales for each segment are discussed below, in the respective segment discussion.

North America. North American Net sales for the three months ended September 30, 2011 increased to $279.3 million from $214.7 million for the same period in 2010, an increase of $64.6 million, or 30.1%. Our North American Retail channel contributed $257.0 million in Net sales for the three months ended September 30, 2011 for an increase of $59.5 million, or 30.1%. The TEMPUR-CloudTM collection continues to be well received by retailers and consumers. This latest generation of proprietary TEMPUR® material was developed for consumers who want a soft sleep surface with the underlying support provided by a Tempur-Pedic mattress. Additionally, we believe that our continued advertising investments have had a positive impact on our performance. As a result, North American Mattress sales increased $41.7 million, or 27.7% over the same period in 2010. Net sales in the Direct channel increased by $5.4 million, or 38.0%. We believe increased sales in the Direct channel are a result of our focus on building brand awareness and encouraging consumers to visit our enhanced website through our advertisements. Other Net sales increased $22.0 million, or 48.5%, compared to the same period in 2010. Many of our Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Other products are also positively impacted. Additionally, we have emphasized and continue to experience improved attach rates on adjustable bed bases which are sold at a higher price point than traditional foundations.

 International. International Net sales for the three months ended September 30, 2011 increased to $103.8 million from $81.1 million for the same period in 2010, an increase of $22.7 million, or 27.9%. On a constant currency basis, our International Net sales increased approximately 15.4%. The International Retail channel increased $23.0 million, or 36.6%, compared to the same period in 2010. International Retail Net sales increased primarily because of growth in certain key customers and investing in our brand awareness. Additionally, we continue to introduce the TEMPUR-Cloud™ mattress, which we believe appeals to a different group of consumers, in certain of our International markets. As a result, International Mattress sales in the third quarter of 2011 increased $14.9 million, or 30.9%, over the same period in 2010. Pillow sales for the third quarter of 2011 increased $3.3 million, or 21.0%, compared to the same period in 2010. Other product Net sales increased $4.5 million, or 26.0%, compared to the same period in 2010. Many of our Pillows and Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Pillows and other products are also positively impacted.

Gross profit. Gross profit for the three months ended September 30, 2011 increased to $200.6 million from $150.8 million for the same period in 2010, an increase of $49.8 million, or 33.1%. The Gross profit margin for the three months ended September 30, 2011 was 52.4% as compared to 51.0% for the same period in 2010. Our Gross profit margin is impacted by, among other factors, geographic mix between segments. The principal factors that impacted Gross profit margin during the quarter are identified and discussed below in the respective segment discussions.

North America. North American Gross profit for the three months ended September 30, 2011 increased to $139.7 million from $101.8 million for the same period in 2010, an increase of $37.9 million, or 37.2%.  The Gross profit margin in our North American segment was 50.0% and 47.4% for the three months ended September 30, 2011 and 2010, respectively.  Improvements in our North American Gross profit margin were primarily driven by our productivity programs which generated improved efficiencies in manufacturing and distribution, favorable mix and fixed cost leverage related to higher production volumes. These factors were partially offset by higher commodity costs and strategic investments, including floor model discounts related to new product launches and a program with our retailers allowing their sales associates to purchase our products at a discount. Additionally, the North American segment pays a royalty to our International segment based on its production volume, which has the effect of lowering the segment’s reported Gross profit margin. Our North American Cost of sales for the three months ended September 30, 2011 increased to $139.6 million from $112.9 million for the same period in 2010, an increase of $26.7 million, or 23.7%.

26

International. International Gross profit for the three months ended September 30, 2011 increased to $60.9 million from $48.9 million for the same period in 2010, an increase of $11.9 million, or 24.4%. The Gross Profit margin in our International segment was 58.6% and 60.3% for the three months ended September 30, 2011 and 2010, respectively. The decrease in our International Gross profit margin was primarily driven by strategic investments, including an information technology upgrade at our manufacturing facility in Denmark and floor model discounts related to new product launches; and higher commodity costs.  We experienced increased demand for our new products which, in combination with temporary productivity issues arising from the upgrade, resulted in decreased inventory levels. As a result, we shipped product from North America thereby incurring incremental freight costs. These factors were partially offset by efficiencies in manufacturing. Additionally, the International segment receives a royalty from our North American segment based on the North American production volume, which has the effect of increasing the segment’s reported Gross profit margin. Our International Cost of sales for the three months ended September 30, 2011 increased to $42.9 million from $32.2 million for the same period in 2010, an increase of $10.7 million, or 33.3%.

Selling and marketing expenses. Selling and marketing expenses include advertising and media production associated with our Direct channel, other marketing materials such as catalogs, brochures, videos, product samples, direct customer mailings, point of purchase materials and sales force compensation. We also include in Selling and marketing expenses for certain new product development costs, including market research and new product testing. Selling and marketing expenses increased to $72.4 million for the three months ended September 30, 2011 as compared to $53.2 million for the three months ended September 30, 2010, an increase of $19.2 million, or 36.1%. Selling and marketing expenses as a percentage of Net sales were 18.9% and 18.0% for the three months ended September 30, 2011 and 2010, respectively. Our advertising expenses for the three months ended September 30, 2011 were $39.6 million compared to $25.4 million, an increase of $14.2 million, or 55.7%. Advertising expenses as a percentage of Net sales were 10.3% and 8.6% for the three months ended September 30, 2011 and 2010, respectively.  Our objective is to align advertising costs to reflect our sales expectations. During the three months ended September 30, 2011, we made additional investments to increase our brand awareness in North America and certain international markets. Additionally, to continue to drive consumers to our Retail channel in North America, we continue to invest in our “Ask Me” advertising campaign and our integrated advertising program  with our retailers. All other selling and marketing expenses increased $5.0 million primarily as a result of increased salaries and associated expenses and investments in our website infrastructure to enhance the consumer experience.

General, administrative and other expenses. General, administrative and other expenses include management salaries, information technology, professional fees, depreciation of furniture and fixtures, leasehold improvements and computer equipment, expenses for administrative functions and research and development costs. General, administrative and other expenses as a percentage of Net sales were 8.3% and 10.0% for the three months ended September 30, 2011 and 2010, respectively. General, administrative and other expenses increased to $31.5 million for the three months ended September 30, 2011 as compared to $29.4 million for the same period in 2010, an increase of $2.2 million, or 7.4%. The increase in General, administrative and other expenses are primarily a result of increased investments in information technology, stock-based compensation, salaries and associated expenses, and research and development, all of which were driven by our continued growth.

Interest expense, net. Interest expense, net, includes the interest costs and other expenses associated with our borrowings and the amortization of deferred financing costs. Interest expense, net, decreased to $3.3 million for the three months ended September 30, 2011 as compared to $4.1 million for the same period in 2010, a decrease of $0.8 million, or 19.7%. The decrease in interest expense is primarily attributable to a decrease in the portion of the underlying debt subject to our interest rate swap, which expired on May 31, 2011, offset by an increase in debt outstanding. The interest rate on our variable rate debt was lower than the fixed rate of the interest rate swap.

On August 8, 2011, the Company entered into a new four-year interest rate swap agreement effective December 30, 2011 to manage interest costs and the risk associated with changing interest rates associated with a portion of the borrowings outstanding under the Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding the Company’s derivative instruments, including this interest rate swap.

If we increase our borrowings, we are subject to variable rate debt that is not protected under the interest rate swap described above. Accordingly, if interest rates increase we may incur a higher level of interest expense. The variable interest rate and certain fees that we pay in connection with our credit facility are subject to periodic adjustment based on changes in our consolidated leverage ratio.

27

Income tax provision. Income tax provision includes income taxes associated with taxes currently payable and deferred taxes, and it includes the impact of net operating losses for certain of our foreign operations. Our effective tax rate for the three months ended September 30, 2011 and September 30, 2010 was 33.5% and 30.5%, respectively.  The difference between the September 30, 2011 and September 30, 2010 rates is primarily related to the geographical mix of earnings experienced in the third quarter of 2011 as compared to the third quarter of 2010.

Nine Months Ended September 30, 2011 Compared with Nine Months Ended September 30, 2010

A summary of Net sales, by channel and by segment, is set forth below:

	CONSOLIDATED				NORTH AMERICA				INTERNATIONAL
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,				September 30,				September 30,
(In thousands)	2011		2010		2011		2010		2011		2010
Retail	$	926,258	$	698,626	$	692,383	$	513,969	$	233,875	$	184,657
Direct		71,479		54,503		54,844		44,950		16,635		9,553
Healthcare		25,073		25,954		8,215		9,200		16,858		16,754
Third Party		28,325		33,635		—		5,343		28,325		28,292
	$	1,051,135	$	812,718	$	755,442	$	573,462	$	295,693	$	239,256

A summary of Net sales, by product and by segment, is set forth below:

	CONSOLIDATED				NORTH AMERICA				INTERNATIONAL
	Nine Months Ended				Nine Months Ended				Nine Months Ended
	September 30,				September 30,				September 30,
(In thousands)	2011		2010		2011		2010		2011		2010
Mattresses	$	705,759	$	546,854	$	527,398	$	405,013	$	178,361	$	141,841
Pillows		107,717		92,630		53,502		46,494		54,215		46,136
Other		237,659		173,234		174,542		121,955		63,117		51,279
	$	1,051,135	$	812,718	$	755,442	$	573,462	$	295,693	$	239,256

Net sales. Net sales for the nine months ended September 30, 2011 increased to $1,051.1 million from $812.7 million for the same period in 2010, an increase of $238.4 million, or 29.3%. During 2011, we have experienced a significant improvement in Net sales. We believe our revenues have continued gaining momentum primarily as a result of investments made in marketing, the success of new product introductions and expanding points of distribution. Consolidated Mattress sales increased $158.9 million, or 29.1%, compared to the nine months ended September 30, 2010. The increase in Mattress sales occurred primarily in our Retail channel with net sales for the nine months increasing to $926.3 million from $698.6 million for the same period in 2010, an increase of $227.6 million, or 32.6%. Consolidated Pillow sales increased $15.1 million, or 16.3%, compared to the same period in 2010. Consolidated Other, which primarily includes adjustable bed bases, foundations and other related products, increased $64.4 million, or 37.2%. Many of our Pillows and Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Pillows and Other products are also positively impacted. The principal factors that impacted Net sales for each segment are discussed below, in the respective segment discussion.

North America. North American Net sales for the nine months ended September 30, 2011 increased to $755.4 million from $573.5 million for the same period in 2010, an increase of $182.0 million, or 31.7%. Our North American Retail channel contributed $692.4 million in Net sales for the nine months ended September 30, 2011 for an increase of $178.4 million, or 34.7%, compared to the same period in 2010. The TEMPUR-Cloud™ collection continues to be well received by retailers and consumers.  Additionally, we believe that our continued advertising investments have had a positive impact on our performance.  As a result, North American mattress sales increased $122.4 million, or 30.2%, over the same period in 2010, driven by the increase in our Retail channel. Net sales in the Direct channel increased to $54.8 million from $45.0 million during the same period in 2010, an increase of $9.9 million, or 22.0%. We believe increased sales in the Direct channel are a result of our focus on building brand awareness and encouraging consumers to visit our enhanced website through our advertisements. The Third Party channel Net sales decrease is attributable to our April 1, 2010 acquisition of our third-party distributor in Canada. Other Net sales increased $52.6 million, or 43.1%, compared to the same period in 2010. Many of our Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Other products are also positively impacted. Additionally, we have emphasized and continue to experience improved attach rates on adjustable bed bases which are sold at a higher price point than traditional foundations.

28

International. International Net sales for the nine months ended September 30, 2011 increased to $295.7 million from $239.3 million for the same period in 2010, an increase of $56.4 million, or 23.6%. On a constant currency basis, our International Net sales increased approximately 13.6%. The International Retail channel increased $49.2 million, or 26.7%, for the nine months ended September 30, 2011. International Retail Net sales increased primarily because of growth in certain key customers and investing in our brand awareness. Additionally, we introduced the TEMPUR-Cloud™ mattress, which we believe appeals to a different group of consumers, in certain of our International markets. As a result, International mattress sales increased $36.5 million, or 25.7%, as compared to 2010. Pillow sales for 2011 increased $8.1 million, or 17.5%, compared to the same period in 2010. Other product Net sales increased $11.8 million, or 23.1%, as compared to 2010. Many of our Pillows and Other products are sold with mattress purchases. Therefore, when Mattress sales increase, Pillows and Other products are also positively impacted.

                Gross profit. Gross profit for the nine months ended September 30, 2011 increased to $551.9 million from $403.6 million for the same period in 2010, an increase of $148.3 million, or 36.7%.  The Gross profit margin for the nine months ended September 30, 2011 was 52.5% as compared to 49.7% for the same period in 2010. Our Gross profit margin is impacted by, among other factors, geographic mix between segments. The principal factors that impacted Gross profit margin during the quarter are identified and discussed below in the respective segment discussions.

                North America. North American Gross profit for the nine months ended September 30, 2011 increased to $375.8 million from $263.8 million for the same period in 2010, an increase of $112.0 million, or 42.5%.  The Gross profit margin in our North American segment was 49.7% and 46.0% for the nine months ended September 30, 2011 and 2010, respectively.  Improvements in our North American Gross profit margin were primarily driven by our productivity programs which generated improved efficiencies in manufacturing and distribution, favorable mix and fixed cost leverage related to higher production volumes, offset by higher commodity costs and floor model discounts related to new product launches. Additionally, the North American segment pays a royalty to our International segment based on its production volume, which has the effect of lowering the segment’s reported Gross profit margin. Our North American cost of sales increased to $379.7 million for the nine months ended September 30, 2011 as compared to $309.7 million for the nine months ended September 30, 2010, an increase of $70.0 million, or 22.6%.

International. International Gross profit for the nine months ended September 30, 2011 increased to $176.2 million from $139.9 million for the same period in 2010, an increase of $36.3 million, or 26.0%. The Gross profit margin in our International segment was 59.6% and 58.5% for the nine months ended September 30, 2011 and September 30, 2010, respectively. For the nine months ended September 30, 2011, improvements in our International Gross profit margin were primarily driven by improved efficiencies in manufacturing, favorable mix and fixed cost leverage related to higher production volumes. These factors were partially offset by higher commodity costs and strategic investments, including an information technology upgrade at our manufacturing facility in Denmark and floor model discounts related to new product launches. During the third quarter, we experienced increased demand for our new products which, in combination with temporary productivity issues arising from the upgrade, resulted in decreased inventory levels. As a result, we shipped product from North America thereby incurring incremental freight costs. Additionally, the International segment receives a royalty from our North American segment based on their production volume, which has the effect of increasing the segment’s reported Gross profit margin. Our International Cost of sales for the nine months ended September 30, 2011 increased to $119.5 million from $99.4 million for the same period in 2010, an increase of $20.1 million, or 20.2%.

Selling and marketing expenses. Selling and marketing expenses increased to $204.8 million for the nine months ended September 30, 2011 as compared to $146.3 million for the nine months ended September 30, 2010, an increase of $58.5 million, or 40.0%. Selling and marketing expenses as a percentage of Net sales increased to 19.5% for the nine months ended September 30, 2011 from 18.0% for the same period for 2010. Our advertising expenses for the nine months ended September 30, 2011 were $109.8 million compared to $70.6 million for the same period in 2010, an increase of $39.3 million, or 55.6%. Advertising expenses as a percentage of Net sales were 10.4% and 8.7% for the nine months ended September 30, 2011 and 2010, respectively. Our objective is to align advertising costs to reflect our sales expectations. During 2011 we made additional investments to increase our brand awareness in North America and certain international markets. Additionally, to continue to drive consumers to our Retail channel in North America, we continue to invest in our “Ask Me” advertising campaign and have introduced an integrated advertising program with our retailers. All other selling and marketing expenses increased $19.3 million primarily as a result of increased salaries and associated expenses and investments in our website infrastructure to enhance the customer experience.

29

General, administrative and other expenses. General, administrative and other expenses increased to $92.4 million for the nine months ended September 30, 2011 as compared to $83.0 million for the nine months ended September 30, 2010, an increase of $9.4 million, or 11.3%. General, administrative and other expenses as a percentage of Net sales were 8.8% and 10.2% for the nine months ended September 30, 2011 and September 30, 2010, respectively. The increase in General, administrative and other expenses are primarily a result of increased investments in information technology, stock-based compensation, salaries and associated expenses, and research and development, all of which were driven by our continued growth. The effects of these items have been partially offset by lower professional fees in 2011 compared to 2010 which reflects the acquisition of our former third-party distributor in Canada on April 1, 2010, and favorable settlements of certain non-income taxes with certain regulatory authorities.

Interest expense, net. Interest expense, net, decreased to $8.5 million for the nine months ended September 30, 2011, as compared to $11.0 million for the nine months ended September 30, 2010, a decrease of $2.6 million, or 23.5%.  The decrease in interest expense is primarily attributable to a decrease in the portion of the underlying debt subject to our interest rate swap, which expired on May 31, 2011, offset by an increase in debt outstanding. The interest rate on our variable rate debt was lower than the fixed rate of the interest rate swap.

On August 8, 2011, the Company entered into a new four-year interest rate swap agreement effective December 30, 2011 to manage interest costs and the risk associated with changing interest rates associated with a portion of the borrowings outstanding under the Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding the Company’s derivative instruments, including this interest rate swap.

If we increase our borrowings, we are subject to variable rate debt that is not protected under the interest rate swap described above. Accordingly, if interest rates increase we may incur a higher level of interest expense. The variable interest rate and certain fees that we pay in connection with our credit facility are subject to periodic adjustment based on changes in our consolidated leverage ratio.

Income tax provision. Our effective tax rate for the nine months ended September 30, 2011 was 33.4%.  For the same period in 2010, the effective tax rate was 31.9%.  The increase in the effective tax rate is primarily related to the geographical mix of earnings experienced for the nine months ended September 30, 2011 compared to the same period in 2010.

Liquidity and Capital Resources

Liquidity

Our principal sources of funds are cash flows from operations, borrowings made pursuant to our Senior Credit Facility and Cash and cash equivalents on hand. Principal uses of funds consist of share repurchases made from time to time pursuant to share repurchase authorizations, payments of principal and interest on our Senior Credit Facility, acquisitions of certain former third party distributors, capital expenditures and working capital needs. At September 30, 2011, we had working capital of $194.4 million including Cash and cash equivalents of $103.0 million compared to working capital of $125.2 million including $53.6 million in Cash and cash equivalents as of December 31, 2010.

                Our cash flow from operations increased to $179.0 million for the nine months ended September 30, 2011 from $139.7 million for the nine months ended September 30, 2010. The increase in operating cash flow for the nine months ended September 30, 2011 compared to nine months ended September 30, 2010 was primarily driven by Net income growth, partially offset by changes in Operating assets and liabilities due to increases in Accounts Receivable and Inventories.

Net cash used in investing activities decreased to $25.4 million for the nine months ended September 30, 2011 as compared to $31.2 million for the nine months ended September 30, 2010. This decrease reflects the acquisition of our former third party distributor in Canada during 2010, partially offset by an increase in capital expenditures. In 2011, we are making strategic investments, including an information technology upgrade, and capital projects that we believe will create long-term operational efficiencies and support future growth.

Cash flow used by financing activities was $102.3 million for the nine months ended September 30, 2011 compared to cash flow used of $84.7 million for the same period in 2010, representing an increase of $17.6 million. This increase is primarily related to decreased net borrowings under the Senior Credit Facility and deferred financing costs associated with the amended and restated Senior Credit Facility. Cash flows from financing activities also increased as the amount of deductions taken on the Company’s income tax returns for certain stock-based compensation awards exceeded cumulative compensation cost recognized on the financial statements due to increased stock option exercises and the company’s stock price.  These increases were partially offset by a decrease in shares repurchased.

30

Capital Expenditures

Capital expenditures totaled $18.8 million for the nine months ended September 30, 2011 and $12.3 million for the nine months ended September 30, 2010. We currently expect our 2011 capital expenditures to be approximately $28.0 million. This expected increase in capital expenditures in 2011 is attributable to strategic investments that we believe will create long-term operational efficiencies and support future growth.

Debt Service

Our long-term debt increased to $508.5 million as of September 30, 2011 from $407.0 million as of December 31, 2010. Aftergiving effect to $508.5 million in borrowings under the Senior Credit Facility and letters of credit outstanding of $1.0 million, total availability under the Revolvers was $260.5 million as of September 30, 2011. On June 28, 2011, the Company amended and restated its Senior Credit Facility, as amended, which increased the total availability under the facility to an aggregate of $770.0 million, added an option to increase domestic availability by an additional $250.0 million, extended the maturity date to June 28, 2016 and increased the applicable margins and certain fees to current market conditions.

As of September 30, 2011, we are in compliance with our debt covenants. The table below sets forth the calculation of our compliance with the Funded debt to Earnings Before Interest Taxes Depreciation and Amortization (EBITDA) covenant. Both Funded debt and EBITDA are terms that are not recognized under U.S. GAAP and do not purport to be alternatives to Net income as a measure of operating performance or Total debt.

Reconciliation of Net income to EBITDA

The following table sets forth the reconciliation of the Company’s reported Net income to the calculation of EBITDA for the trailing twelve months ended September 30, 2011:

	Three Months Ended								Twelve Months Ended
(In thousands)	December 31, 2010		March 31, 2011		June 30, 2011		September 30, 2011		September 30, 2011
GAAP Net income	$	46,292	$	48,260	$	53,084	$	61,949	$	209,585
Plus:
Interest expense		3,458		2,539		2,646		3,265		11,908
Income taxes		21,890		23,878		26,982		31,164		103,914
Depreciation & Amortization		12,146		11,070		13,239		12,166		48,621
EBITDA	$	83,786	$	85,747	$	95,951	$	108,544	$	374,028

Reconciliation of Total debt to Funded debt

The following table sets forth the reconciliation of the Company’s reported Total debt to the calculation of Funded debt and Funded debt to EBITDA ratio as of September 30, 2011:

	As of
(In thousands)	September 30, 2011
GAAP basis Total debt	$	508,500
Plus:
Letters of credit outstanding		990
Funded debt	$	509,490
EBITDA	$	374,028
Funded debt to EBITDA		1.36 times

The ratio of Funded debt to EBITDA was 1.36 times, within the covenant in the Senior Credit Facility, which requires this ratio not exceed 3.0 times.

31

Stockholders’ Equity

Share Repurchase Program. During the nine months ended September 30, 2011, we purchased 4.3 million shares of our common stock for a total cost of $240.0 million pursuant to the authorizations adopted by our Board of Directors in January and July 2011. On July 25, 2011, our Board of Directors terminated the remaining authority under the January 2011 authorization and approved a new share repurchase authorization of up to $200.0 million of our common stock. As of September 30, 2011, we had $120.0 million remaining under the July 2011 authorization. On October 18, 2011, our Board of Directors approved the purchase of an additional $80.0 million of our common stock under the previously approved July 2011 authorization, increasing the total available for repurchase to $200.0 million. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under our credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice.

Use of Non-GAAP Measures

We provide information regarding EBITDA and Funded debt which are not recognized terms under U.S. GAAP and do not purport to be alternatives to Net income as a measure of operating performance or Total debt. Because not all companies use identical calculations, these presentations may not be comparable to other similarly titled measures of other companies. A reconciliation of EBITDA to our Net income and a reconciliation of Funded debt to Total debt have been provided in this Management’s Discussion and Analysis and we believe the use of these non-GAAP financial measures provide investors with additional useful information with respect to our Senior Credit Facility.

Factors That May Affect Future Performance

General Business and Economic Conditions. Our business has been affected by general business and economic conditions, and these conditions could have an impact on future demand for our products. The U.S. macroeconomic environment was challenging in 2009 and was the primary factor in a slowdown in the mattress industry. In 2010, the U.S. macroeconomic environment improved slightly, but remained uncertain. In addition, our international segment has experienced weakening as a result of general business and economic conditions. We expect the global economic environment to continue to be challenging for the remainder of 2011.

Our objective is to align our cost structure with our anticipated level of Net sales. As a result, during the remainder of 2011, we expect to continue to pursue certain key strategies including: maintaining focus on premium mattresses and pillows and introducing new products; investing in increasing our global brand awareness; extending our presence and improving our Retail account productivity and distribution; investing in our operating infrastructure to meet the requirements of our business; and taking actions to further strengthen our business.

Managing Growth. Over the last few years, we have had to manage our business both through periods of rapid growth and the economic downturn. Our Net sales increased from $221.5 million in 2001 to $1.1 billion in 2007 and decreased to $927.8 million in 2008 and $831.2 million in 2009. During the year ended December 31, 2010, our Net sales increased to $1.1 billion. For the nine months ended September 30, 2011, our Net sales were $1.1 billion. In the past, our growth has placed, and may continue to place, a strain on our management, production, product distribution network, information systems and other resources. In response to these types of challenges, management has continued to enhance operating and financial infrastructure, as appropriate. In addition, during 2007 through 2009, we had to manage a decline in sales as a result of the macroeconomic environment. During this period, we had to manage our cost structure to contain costs. Going forward, we expect our expenditures to enhance our operating and financial infrastructure, as well as expenditures for advertising and other marketing-related activities, will continue to be made as the continued growth in the business allows us the ability to make strategic investments. However, these expenditures may be limited by lower than planned sales or an inflationary cost environment.

32

Gross Margins. Our gross margin is primarily impacted by fixed cost leverage, the cost of raw materials, operational efficiency, product, channel and geographic mix, volume incentives offered to certain retail accounts and costs associated with new product introductions. We experienced increases in the price of certain raw materials during the nine months ended September 30, 2011. Future increases in raw material prices could have a negative impact on our gross margin if we do not raise prices to cover increased cost. Our gross margin can also be impacted by our operational efficiencies, including the particular levels of utilization at our three manufacturing facilities. We have made significant investments in our manufacturing infrastructure and have significant available manufacturing capacity. If we increase our Net sales significantly the effect of this operating leverage could have a significant positive impact on our gross margin. Our margins are also impacted by the growth in our Retail channel as sales in our Retail channel are at wholesale prices whereas sales in our Direct channel are at retail prices. Additionally, our overall product mix has shifted to mattresses and other products over the last several years, which has impacted our gross margins because mattresses generally carry lower margins than pillows and are sold with lower margin products such as adjustable bed bases and foundations. We expect our gross margins to be up for the full year 2011 driven by favorable mix, continued productivity programs and volume leverage, partially offset by strategic investments and increased commodity costs.

Competition. Participants in the mattress and pillow industries compete primarily on price, quality, brand name recognition, product availability and product performance. We compete with a number of different types of mattress alternatives, including standard innerspring mattresses, other foam mattresses, waterbeds, futons, air beds and other air-supported mattresses. These alternative products are sold through a variety of channels, including furniture and bedding stores, specialty bedding stores, department stores, mass merchants, wholesale clubs, telemarketing programs, television infomercials, television advertising and catalogs.

Our largest competitors have significant financial, marketing and manufacturing resources and strong brand name recognition, and sell their products through broad and well established distribution channels. Additionally, we believe that a number of our significant competitors offer mattress products claimed to be similar to our TEMPUR® mattresses and pillows. We provide strong channel profits to our retailers and distributors which management believes will continue to provide an attractive business model for our retailers and discourage them from carrying competing lower-priced products.

Significant Growth Opportunities. We believe there are significant opportunities to take market share from the innerspring mattress industry as well as other sleep surfaces. Our market share of the overall mattress industry is relatively small in terms of both dollars and units, which we believe provides us with a significant opportunity for growth. By broadening our brand awareness and offering superior sleep surfaces, we believe consumers will over time adopt our products at an increasing rate, which should expand our market share. However, our business may be affected by general business and economic conditions that could have an impact on demand for our products.

Additionally, by expanding distribution within our existing accounts, we believe we have the opportunity to grow our business. By extending our product line and our new segmentation of products, we should be able to continue to expand the number of Tempur-Pedic models offered at the retail store level, which should lead to increased sales. Based on this strategy we believe a focus on expanding distribution within our existing accounts provides for continued growth opportunities and market share gains. During the second quarter of 2011, we introduced our latest product line, the TEMPUR®-Contour collection. However, our business may continue to be affected by general business and economic conditions that could have an impact on demand for our products, which could limit our market share and decrease sales. Our products are currently sold in approximately 7,600 furniture and bedding retail stores in the North American segment, out of a total of approximately 11,500 stores we have identified as appropriate targets. Within this addressable market, our plan is to increase our total penetration to a total of 8,000 to 9,000 over time. Our products are also sold in approximately 5,200 furniture retail and department stores in the International segment, out of a total of approximately 8,000 stores that we have identified as appropriate targets. We are continuing to develop products that are responsive to consumer demand in our markets internationally.

33

Financial Leverage. As of September 30, 2011, we had $508.5 million of total Long-term debt outstanding, and Stockholders’ equity of $99.4 million. Higher financial leverage makes us more vulnerable to general adverse competitive, economic and industry conditions. On June 28, 2011, we amended and restated our Senior Credit Facility, as amended, which increased the total availability under the facility to an aggregate of $770.0 million, added an option to increase domestic availability by an additional $250.0 million, extended the maturity date to June 28, 2016 and increased the applicable margins and certain fees to current market conditions. There can be no assurance, however, that our business will generate sufficient cash flow from operations or that future borrowings will be available under our Senior Credit Facility. As of September 30, 2011, our ratio of funded debt to EBITDA was 1.36 times, within the covenant in our Senior Credit Facility, which requires this ratio not exceed 3.0 times. Our target leverage ratio is 1.5 to 2.0 times. On August 8, 2011, we entered into a new four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates associated with a portion of the borrowings outstanding under the Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding our derivative instruments, including this interest rate swap.

Exchange Rates. As a multinational company, we conduct our business in a wide variety of currencies and are therefore subject to market risk for changes in foreign exchange rates. We use foreign exchange forward contracts to manage a portion of the risk of the eventual net cash inflows and outflows resulting from foreign currency denominated transactions between Tempur-Pedic subsidiaries and their customers and suppliers, as well as between the Tempur-Pedic subsidiaries themselves. These hedging transactions may not succeed in effectively managing our foreign currency exchange rate risk. We typically do not apply hedge accounting to these contracts. See “ITEM 3. Quantitative and Qualitative Disclosures About Market Risk—Foreign Currency Exposures” under Part I of this report.

Critical Accounting Policies and Estimates

 For a discussion of our critical accounting policies and estimates, see “ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2010. There have been no material changes to our critical accounting policies and estimates in 2011.

 ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Foreign Currency Exposures

As a global company, we conduct our business in a wide variety of currencies and are therefore subject to market risk for changes in foreign exchange rates. Foreign currency exchange rate movements create a degree of risk by affecting the U.S. dollar value of sales made and costs incurred in foreign currencies. We typically do not enter into hedging transactions to hedge this risk.  Consequently, our reported earnings and financial position could fluctuate materially as a result of foreign exchange movements. Should currency rates change sharply, our results could be impacted.

We protect a portion of our currency exchange exposure with foreign currency forward contracts. A sensitivity analysis indicates the potential loss in fair value on foreign currency forward contracts outstanding at September 30, 2011, resulting from a hypothetical 10% adverse change in all foreign currency exchange rates against the U.S. dollar, is approximately $0.06 million.  Such losses would be largely offset by gains from the revaluation or settlement of the underlying assets and liabilities that are being protected by the foreign currency forward contracts.

We typically do not apply hedge accounting to the foreign currency forward contracts used to offset currency-related changes in the fair value of foreign currency denominated assets and liabilities. These contracts are marked-to-market through earnings at the same time that the exposed assets and liabilities are remeasured through earnings.

34

Interest Rate Risk

We are exposed to changes in interest rates. Our Senior Credit Facility has a variable rate. On August 8, 2011, we entered into a new four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates associated with our Senior Credit Facility. For additional details regarding the interest rate swap and the effect of the amendment see the Notes to the Condensed Consolidated Financial Statements in “Item 1. Financial Statements,” under Part I of this report.

Interest rate changes generally do not affect the market value of such debt, but do impact the amount of our interest payments and therefore, our future earnings and cash flows, assuming other factors are held constant. On September 30, 2011, we had variable-rate debt of approximately $508.5 million. Holding other variables constant, including levels of indebtedness, a one hundred basis point increase in interest rates on our variable-rate debt would cause an estimated reduction in income before income taxes for the next year of approximately $7.6 million.

 ITEM 4. CONTROLS AND PROCEDURES

An evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were effective as of September 30, 2011 and designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

                During the quarter ended September 30, 2011, the Company upgraded its information technology (IT) system at our manufacturing facility in Denmark. As a result, internal controls in this location related to user security, account structure and hierarchy, system reporting and approval procedures were modified and redesigned to conform with and support the IT system upgrade. Otherwise, there were no significant changes in the Company’s internal controls over financial reporting, or in other factors, that occurred during the periods covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See Note 9 to the Notes to the Condensed Consolidated Financial Statements in ITEM 1 under Part I of this report for a full description of our legal proceedings.

We are involved in various other legal proceedings incidental to the operations of our business. We believe that the outcome of all such pending legal proceedings in the aggregate will not have a materially adverse affect on our business, financial condition, liquidity or operating results.

35

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “ITEM 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2010, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and operating results.

We are subject to a pending tax proceeding in Denmark and an adverse decision would reduce our liquidity and profitability.

During the fourth quarter of 2007, we received an income tax assessment from the Danish Tax Authority with respect to the 2001, 2002 and 2003 tax years, an assessment with respect to the 2004 tax year during the third quarter of 2010, and an assessment with respect to the 2005 tax year during the second quarter of 2011.  The tax assessments relate to the royalty paid by one of Tempur-Pedic International’s U.S. subsidiaries to a Danish subsidiary and the position taken by the Danish Tax Authority could apply to subsequent years. The total tax assessment is approximately $103.1 million including interest and penalties.  In the first quarter of 2008 and the third quarter of 2010, we filed timely complaints with the Danish National Tax Tribunal denying the tax assessments.  The National Tax Tribunal formally agreed to place the Danish tax litigation on hold pending the outcome of a Bilateral Advance Pricing Agreement (Bilateral APA) between the United States and the Danish Tax Authority.  A Bilateral APA involves an agreement between the Internal Revenue Service (IRS) and the taxpayer, as well as a negotiated agreement with one or more foreign competent authorities under applicable income tax treaties.  During the third quarter of 2008 we filed the Bilateral APA with the IRS and the Danish Tax Authority.  U.S. and Danish competent authorities initially met to discuss the Company’s Bilateral APA during the first quarter of 2011 and additional meetings are expected. We believe we have meritorious defenses to the proposed adjustments and will oppose the assessments in the Danish courts, as necessary. It is reasonably possible the amount of unrecognized tax benefits may change in the next twelve months.  An estimate of the amount of such change cannot be made at this time.

 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) Not applicable.

(b) Not applicable.

(c) Issuer Purchases of Equity Securities

The following table sets forth purchases of our common stock for the three months ended September 30, 2011:

Period	(a) Total  number of shares purchased	(b) Average Price Paid per Share		(c) Total number of shares purchased as part of publicly announced plans or programs	(d) Maximum number of  shares (or approximate dollar value) of shares that may yet be purchased under the plans or programs (in millions)
July 1, 2011 – July 31, 2011	—		—	—		—
August 1, 2011 – August 31, 2011	816,814	$	61.20	816,814	$	150.0
September 1, 2011 – September 30, 2011	521,080	$	57.57	521,080	$	120.0
Total	1,337,894			1,337,894

On January 13, 2011, our Board of Directors authorized the repurchase of up to $200.0 million of our common stock. On July 25, 2011, our Board of Directors terminated the remaining authority under the January 2011 authorization and approved a new share repurchase authorization of up to $200.0 million of our common stock. On October 18, 2011 our Board of Directors approved the purchase of an additional $80.0 million of the Company’s common stock under the previously approved July 2011 authorization, increasing the total available for repurchase to $200.0 million.

36

 ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

 ITEM 5. OTHER INFORMATION

(a) Not applicable.

(b) Not applicable.

ITEM 6. EXHIBITS

                The following is an index of the exhibits included in this report:

31.1		Certification of Chief Executive Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	*	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
10.1		The following materials from Tempur-Pedic International Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text.
	*	This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78r), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any filings.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TEMPUR-PEDIC INTERNATIONAL INC.
October 25, 2011	By:	/s/ DALE E. WILLIAMS
		Dale E. Williams
		Executive Vice President and Chief Financial Officer

38

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Sarvary, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2011, of Tempur-Pedic International Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 25, 2011	By:	/s/ MARK SARVARY
		Mark Sarvary
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dale E. Williams, certify that:

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended September 30, 2011, of Tempur-Pedic International Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 25, 2011	By:	/s/ DALE E. WILLIAMS
		Dale E. Williams
		Executive Vice President and Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Tempur-Pedic International Inc. (the “Company”), that, to his knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2011, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company. This written statement is being furnished to the Securities and Exchange Commission as an exhibit to such Form 10-Q. A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Date: October 25, 2011	By:	/s/ MARK SARVARY
		Mark Sarvary
		President and Chief Executive Officer
Date: October 25, 2011	By:	/s/ DALE E. WILLIAMS
		Dale E.Williams
		Executive Vice President and Chief Financial Officer

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) In Thousands	Sep. 30, 2011	Dec. 31, 2010
Current Assets:
Cash and cash equivalents	$ 103,015	$ 53,623
Accounts receivable, net	151,419	115,630
Inventories	91,046	69,856
Prepaid expenses and other current assets	23,456	18,646
Deferred income taxes	11,522	13,725
Total Current Assets	380,458	271,480
Property, plant and equipment, net	158,567	159,807
Goodwill	212,768	212,468
Other intangible assets, net	67,715	68,745
Other non-current assets	9,128	3,503
Total Assets	828,636	716,003
Current Liabilities:
Accounts payable	70,411	48,288
Accrued expenses and other current liabilities	89,456	85,469
Income taxes payable	26,173	12,477
Total Current Liabilities	186,040	146,234
Long-term debt	508,500	407,000
Deferred income taxes	29,368	32,315
Other non-current liabilities	5,291	4,421
Total Liabilities	729,199	589,970
Commitments and contingencies-see Note 9
Total Stockholders' Equity	99,437	126,033
Total Liabilities and Stockholders' Equity	$ 828,636	$ 716,003

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 163,293	$ 110,852
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	25,340	23,870
Amortization of stock-based compensation	11,135	7,953
Amortization of deferred financing costs	689	517
Bad debt expense	1,285	2,072
Deferred income taxes	(480)	2,604
Foreign currency adjustments and other	911	(423)
Changes in operating assets and liabilities	(23,194)	(7,731)
Net cash provided by operating activities	178,979	139,714
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of business, net of cash acquired	(4,566)	(18,692)
Acquisition of trademarks and other	(1,980)	(152)
Purchases of property, plant and equipment	(18,841)	(12,330)
Net cash used by investing activities	(25,387)	(31,174)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from long-term revolving credit facility	682,000	289,336
Repayments of long-term revolving credit facility	(580,500)	(149,313)
Payments of deferred finance costs	(6,192)	0
Proceeds from issuance of common stock	24,419	22,015
Excess tax benefit from stock based compensation	17,956	3,282
Treasury shares repurchased	(240,000)	(250,000)
Net cash used by financing activities	(102,317)	(84,680)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(1,883)	146
Increase in cash and cash equivalents	49,392	24,006
CASH AND CASH EQUIVALENTS, beginning of period	53,623	14,042
CASH AND CASH EQUIVALENTS, end of period	103,015	38,048
Cash paid during the period for:
Interest	7,939	10,008
Income taxes, net of refunds	$ 49,266	$ 38,967

XML

Other Items (Tables)

9 Months Ended

Sep. 30, 2011

Disclosure Text Block Supplement [Abstract]

Property, Plant and Equipment, net

(a) Property, plant and equipment.  Property, plant and equipment, net consisted of the following:

	September 30, 2011			December 31, 2010
Land and buildings	$	122,690		$	121,188
Machinery and equipment, furniture and fixtures and other		225,218			208,310
Construction in progress		9,834			9,858
		357,742			339,356
Accumulated depreciation		(199,175	)		(179,549	)
	$	158,567		$	159,807

Accrued Expenses and Other Current Liabilities

(b) Accrued expenses and other current liabilities. Accrued expenses and other current liabilities consisted of the following:

	September 30,2011		December 31, 2010
Salary and related expenses	$	20,996	$	22,171
Accrued unrecognized tax benefits		12,398		12,035
Advertising accrual		10,443		6,981
Accrued sales and value added taxes		9,881		10,614
Warranty accrual		4,730		4,081
Sales returns		4,925		4,402
Other		26,083		25,185
	$	89,456	$	85,469

Accumulated Other Comprehensive Income

(c) Accumulated other comprehensive loss. Accumulated other comprehensive loss consisted of the following:

	September 30, 2011			December 31, 2010
Derivative instruments accounted for as hedges, net of taxes of $904 and $558, respectively	$	(1,414	)	$	(872	)
Foreign currency adjustments		(8,174	)		(5,316	)
Accumulated other comprehensive loss	$	(9,588	)	$	(6,188	)

Comprehensive Income

(d) Comprehensive income. The components of comprehensive income consisted of the following:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011			2010
Net income	$	61,949		$	44,198	$	163,293		$	110,852
Derivative instruments accounted for as hedges, net of taxes of $904, $499, $346 and $1,561, respectively		(1,414	)		781		(542	)		2,442
Foreign currency adjustments		(14,344	)		11,744		(2,858	)		(1,472	)
Total comprehensive income	$	46,191		$	56,723	$	159,893		$	111,822

XML

Document And Entity Information (USD $)	9 Months Ended
	Sep. 30, 2011	Oct. 25, 2011	Jun. 30, 2010
Entity Registrant Name	TEMPUR PEDIC INTERNATIONAL INC
Entity Central Index Key	0001206264
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 2,011,235,607
Entity Common Stock, Shares Outstanding		65,930,898
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q3
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2011

XML

Business Segment Information (Tables)

9 Months Ended

Sep. 30, 2011

Business Segment Information [Abstract]

Business Segment Information

The following table summarizes Total assets by segment:

	September 30, 2011			December 31, 2010
Total assets:
North America	$	674,155		$	576,139
International		409,945			338,685
Intercompany eliminations		(255,464	)		(198,821	)
	$	828,636		$	716,003

 The following table summarizes segment information:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Net sales from external customers:
North America
Mattresses	$	192,683	$	150,941	$	527,398	$	405,013
Pillows		19,182		18,307		53,502		46,494
Other		67,462		45,439		174,542		121,955
	$	279,327	$	214,687	$	755,442	$	573,462
International
Mattresses	$	63,122	$	48,224	$	178,361	$	141,841
Pillows		18,937		15,652		54,215		46,136
Other		21,699		17,222		63,117		51,279
	$	103,758	$	81,098	$	295,693	$	239,256
	$	383,085	$	295,785	$	1,051,135	$	812,718
Inter-segment sales:
North America	$	2,465	$	169	$	2,778	$	169
International		864		634		2,092		1,295
Intercompany eliminations		(3,329)		(803)		(4,870)		(1,464)
	$	-	$	-	$	-	$	-
Gross Profit
Domestic	$	139,744	$	101,835	$	375,760	$	263,753
International		60,850		48,919		176,162		139,851
	$	200,594	$	150,754	$	551,922	$	403,604
Operating income:
North America	$	69,390	$	45,498	$	179,789	$	108,622
International		27,217		22,656		74,928		65,672
	$	96,607	$	68,154	$	254,717	$	174,294
Depreciation and amortization (including stock-based compensation amortization):
North America	$	9,255	$	8,545	$	28,516	$	25,148
International		2,911		2,233		7,959		6,675
	$	12,166	$	10,778	$	36,475	$	31,823
Capital expenditures:
North America	$	4,434	$	3,116	$	11,392	$	7,043
International		2,309		2,516		7,449		5,287
	$	6,743	$	5,632	$	18,841	$	12,330

XML

Stock-Based Compensation

9 Months Ended

Sep. 30, 2011

Stock-Based Compensation [Abstract]

Stock-Based Compensation

(8) Stock-Based Compensation

The Company currently has three stock-based compensation plans: the 2002 Option Plan (2002 Plan), the Amended and Restated 2003 Equity Incentive Plan (2003 Plan) and the 2003 Employee Stock Purchase Plan (ESPP), which are described under the caption “Stock-based Compensation” in the Notes to the Consolidated Financial Statements of the Company's Annual Report on Form 10-K for the year ended December 31, 2010. Effective February 1, 2010, the Company suspended offerings under the ESPP indefinitely.

In the first quarter of 2010, the Compensation Committee of the Board of Directors approved the terms of a Long-Term Incentive Program (LTIP), established under the 2003 Plan. The LTIP awards consist of a mix of stock options and performance-based restricted stock units (PRSUs). Shares with respect to the PRSUs will be granted, if they vest, following the end of the applicable performance period and achievement of applicable performance metrics as determined by the Compensation Committee of the Board of Directors.

The Company granted PRSUs during the nine months ended September 30, 2011. The maximum number of shares to be awarded under the PRSUs granted during the nine months ended September 30, 2011 will be 443 shares,  and will vest, if earned, at the end of the three-year performance period ending on December 31, 2013. No PRSUs were granted during the three months ended September 30, 2011.  Actual payout under the PRSUs granted is dependent upon the achievement of certain financial goals, based on Net sales and Earnings Before Interest and Taxes (EBIT) margin targets. Based on current estimates of the performance metrics, unrecognized compensation expense with respect to the PRSUs granted in 2011 was $5,401 as of September 30, 2011, which is expected to be recorded over the weighted average remaining life of 2.25 years. The maximum number of shares to be awarded under the PRSUs granted during the nine months ended September 30, 2010 will be 418. No PRSUs were granted during the three months ended September 30, 2010. The Company recorded $1,708 and $359 of compensation expense associated with PRSUs for the three months ended September 30, 2011 and 2010, respectively. The Company recorded $5,719 and $822 of compensation expense associated with PRSUs for the nine months ended September 30, 2011 and 2010, respectively.

The Company granted options to purchase 2 and 85 shares of common stock during the three and nine months ending September 30, 2011, respectively. The Company granted options to purchase 30 and 192 shares of common stock during the three and nine months ending September 30, 2010, respectively. The Company recorded $1,237 and $1,720 of compensation expense associated with options for the three months ended September 30, 2011 and September 30, 2010, respectively. The Company recorded $3,931 and $5,892 of compensation expense associated with options for the nine months ended September 30, 2011 and 2010, respectively. As of September 30, 2011, there was $1,609 of unrecognized compensation expense associated with the options granted in 2011, which is expected to be recorded over the weighted average remaining vesting period of 2.27 years. The options granted in the three months ended September 30, 2011 had a weighted average grant-date fair value of $32.53 per option, as determined by the Black-Scholes option pricing model using the following assumptions:

Expected volatility of stock	73.34	%
Expected life of options, in years	4.0
Risk-free interest rate	0.66	%
Expected dividend yield on stock	0.0	%

The Company granted 9 deferred stock unit (DSU) awards during nine months ended September 30, 2011. The Company granted 188 awards during the nine months ended September 30, 2010 that consisted of restricted stock units (RSUs) and DSUs. No RSUs or DSUs were granted during the three months ended September 30, 2011 or 2010.  As of September 30, 2011, there was $340 of unrecognized compensation expense associated with the DSUs granted in 2011, which is expected to be recorded over the weighted average remaining vesting period of 0.57 years. The Company recorded $471 and $535 of compensation expense associated with RSUs and DSUs for the three months ended September 30, 2011 and September 30, 2010. The Company recorded $1,485 and $1,224 of compensation expense associated with RSUs and DSUs for the nine months ended September 30, 2011 and 2010, respectively.

                The Company recorded $3,416 and $2,614 of total stock-based compensation expense for the three months ended September 30, 2011 and 2010, respectively. The Company recorded $11,135 and $7,953 of total stock-based compensation expense for the nine months ended September 30, 2011 and 2010, respectively.

XML

Summary of Significant Accounting Policies (Details) (USD $) In Thousands	0 Months Ended	3 Months Ended		9 Months Ended
	Oct. 18, 2011	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Inventories [Abstract]
Finished goods		$ 66,354		$ 66,354		$ 53,362
Work-in-process		9,603		9,603		5,549
Raw materials and supplies		15,089		15,089		10,945
Inventory, net		91,046		91,046		69,856
Period allowed product returns (in days)				120 days
Standard Product Warranty Disclosure [Abstract]
North American Sales Warranty Period				20 years
International Sales Warranty Period				15 years
Period Mattresses are Prorated				10 years
Warranty Period on Pillows				2-year to 3-year
Changes in Accrued Sales Returns [Abstract]
Balance as of December 31, 2010	4,925			4,402
Balance as of September 30, 2011		4,925		4,925
Revenue Recognition [Abstract]
Allowance for doubtful accounts included in Accounts receivable, net		6,740		6,740		7,437
Research and Development Expenses [Abstract]
Research and development costs charged to expense		2,373	1,714	7,273	5,263
Additional amount of Company's common stock authorized for repurchase in period	80,000
Total amount of Company's common stock authorized and available for repurchase	200,010
Allowance for Sales Returns [Member]
Changes in Accrued Sales Returns [Abstract]
Balance as of December 31, 2010				4,402
Amounts accrued				36,979
Returns charged to accrual				(36,456)
Balance as of September 30, 2011		4,925		4,925
Warranty Reserves [Member]
Changes in Accrued Sales Returns [Abstract]
Balance as of December 31, 2010				4,081
Amounts accrued				4,012
Warranties charged to accrual				(3,363)
Balance as of September 30, 2011		$ 4,730		$ 4,730

XML

Earnings Per Common Share (Tables)

9 Months Ended

Sep. 30, 2011

Earnings Per Common Share [Abstract]

Earnings Per Common Share

(11) Earnings Per Common Share

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Numerator:
Net income	$	61,949	$	44,198	$	163,293	$	110,852
Denominator:
Denominator for basic earnings per common share-weighted average shares		66,655		69,199		67,722		71,065
Effect of dilutive securities:
Employee stock-based compensation		1,916		2,234		2,125		2,385
Denominator for diluted earnings per common share-adjusted weighted average shares		68,571		71,433		69,847		73,450
Basic earnings per common share	$	0.93	$	0.64	$	2.41	$	1.56
Diluted earnings per common share	$	0.90	$	0.62	$	2.34	$	1.51

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2011

Accounting Policies [Abstract]

Basis of Presentation and Description of Business

(a) Basis of Presentation and Description of Business. Tempur-Pedic International Inc., a Delaware corporation, together with its subsidiaries is a U.S. based, multinational company. The term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the term “Company” refers to Tempur-Pedic International Inc. and its consolidated subsidiaries.

The Company manufactures, markets and sells products including pillows, mattresses and other related products. The Company manufactures essentially all its pressure-relieving TEMPUR® products at three manufacturing facilities, with one located in Denmark and two in the U.S. The Company has sales distribution subsidiaries operating in North America, Europe and Asia Pacific and has third party distribution arrangements in certain other countries where it does not have subsidiaries. The Company sells its products through four sales channels: Retail, Direct, Healthcare and Third party.

                The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States (U.S. GAAP) for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the

consolidated financial statements of the Company and related footnotes for the year ended December 31, 2010, included in the Company's Annual Report on Form 10-K.

                The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein.

Reclassifications

(b) Reclassifications. Certain prior period amounts have been reclassified to conform to the 2011 presentation of Condensed Consolidated Financial Statements, including a reclassification between current Deferred income tax assets and Prepaid expenses and other current assets. Additionally, during the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Income attributable to the noncontrolling interest was not material in 2010 and is presented within Other expense, net in the Condensed Consolidated Statements of Income. These changes do not materially impact previously reported subtotals within the Condensed Consolidated Financial Statements for any previous period presented.

Basis of Consolidation

(c) Basis of Consolidation. The accompanying Condensed Consolidated Financial Statements include the accounts of Tempur-Pedic International and its subsidiaries. All subsidiaries are wholly-owned. During the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Intercompany balances and transactions have been eliminated.

Use of Estimates

(d) Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company's results are affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies and changes in the prices of raw materials, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.

Inventories

(e) Inventories. Inventories are stated at the lower of cost or market, determined by the first-in, first-out method, and consist of the following:

	September 30, 2011		December 31, 2010
Finished goods	$	66,354	$	53,362
Work-in-process		9,603		5,549
Raw materials and supplies		15,089		10,945
	$	91,046	$	69,856

Accrued Sales Returns

(f)Accrued Sales Returns. The Company allows product returns up to 120 days following a sale through certain sales channels and on certain products. Estimated sales returns are provided at the time of sale based on historical sales channel return rates. The level of sales returns differs by channel with the Direct channel typically experiencing the highest rate of return.  Estimated future obligations related to these products are provided by a reduction of sales in the period in which the revenue is recognized. Accrued sales returns are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for sales returns from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,402
Amounts accrued		36,979
Returns charged to accrual		(36,456	)
Balance as of September 30, 2011	$	4,925

Warranties

(g) Warranties. The Company provides a 20-year warranty for North American sales and a 15-year warranty for International sales on mattresses, each prorated for the last 10 years. The Company also provides a 2-year to 3-year warranty on pillows. Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized. Estimates of warranty expenses are based primarily on historical claim experience and product testing. Warranties are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for warranties from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,081
Amounts accrued		4,012
Warranties charged to accrual		(3,363	)
Balance as of September 30, 2011	$	4,730

Revenue Recognition

(h) Revenue Recognition. Sales of products are recognized when persuasive evidence of an arrangement exists, products are shipped and title passes to customers and the risks and rewards of ownership are transferred, the sales price is fixed or determinable and collectability is reasonably assured. The Company extends volume discounts to certain customers and reflects these amounts as a reduction of sales. The Company also reports sales net of tax assessed by qualifying governmental authorities. The Company extends credit based on the creditworthiness of its customers. No collateral is required on sales made in the normal course of business.

The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing accounts receivable. The Company regularly reviews the adequacy of its allowance for doubtful accounts. The Company determines the allowance based on historical write-off experience and current economic conditions. It also considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Account balances are charged off against the allowance after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts included in Accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets was $6,740 and $7,437 as of September 30, 2011 and December 31, 2010, respectively.

Advertising Costs

(i) Advertising Costs. The Company expenses advertising costs as incurred except for production costs and advance payments, which are deferred and expensed when advertisements run for the first time. Direct response advance payments are deferred and are amortized over the life of the program.

Research and Development Expenses

(j) Research and Development Expenses. Research and development expenses for new products are expensed as they are incurred and included in General, administrative and other expenses in the accompanying Condensed Consolidated Statements of Income. Research and development costs charged to expense were $2,373 and $1,714 for the three months ended September 30, 2011 and 2010, respectively. For the nine months ended September 30, 2011 and 2010, research and development costs charged to expense were $7,273 and $5,263, respectively.

Subsequent Events

(k) Subsequent Events. On October 18, 2011, the Company's Board of Directors approved the purchase of an additional $80,000 of the Company's common stock under the previously approved July 2011 authorization. After giving effect to this approval, the total amount authorized and available for repurchase of the Company's common stock under this authorization is $200,010. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under the Company's credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice.

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2011

Fair Value Measurements [Abstract]

Fair Value Measurements

(4) Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset and liability in an orderly transaction between market participants at the measurement date. The Company estimates fair value of its financial instruments utilizing an established three-level hierarchy.

The hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date as follows:

 ● Level 1 – Valuation is based upon unadjusted quoted prices for identical assets or liabilities in active markets.

 ● Level 2 – Valuation is based upon quoted prices for similar assets and liabilities in active markets, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instruments.

 ● Level 3 – Valuation is based upon other unobservable inputs that are significant to the fair value measurements.

                The classification of fair value measurements within the hierarchy is based upon the lowest level of input that is significant to the measurement. There were no transfers between levels for the three months ended September 30, 2011. At September 30, 2011, the Company had an interest rate swap and foreign currency forward contracts recorded at fair value.  Estimates of the fair value of foreign currency derivative instruments are determined using exchange traded prices and rates. The fair value of the interest rate swap is calculated using standard industry models based on observable forward yield curves. The fair values of all derivative instrumentsare adjusted for credit risk and restrictions and other terms specific to the contracts.

The following table provides a summary by level of the fair value of financial instruments that are measured on a recurring basis:

			Fair Value Measurements at September 30, 2011 Using:
	September 30, 2011		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	622	$	-	$	622	$	-
Interest rate swap	$	2,318	$	-	$	2,318	$	-

			Fair Value Measurements at December 31, 2010 Using:
	December 31, 2010		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	676	$	-	$	676	$	-
Interest rate swap	$	1,430	$	-	$	1,430	$	-

The carrying value of Cash and cash equivalents, Accounts receivable and Accounts payable approximate fair value because of the short-term maturity of those instruments. Borrowings under the Senior Credit Facility (as defined in Note 3(b)) are at variable interest rates and accordingly their carrying amounts approximate fair value.

XML

Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Income Taxes [Abstract]
Company's effective tax rate (in hundredths)	33.50%	30.50%	33.40%	31.90%
Federal statutory rate (in hundredths)	35.00%	35.00%	35.00%	35.00%
Undistributed earnings from non-U.S. operations	$ 300,394		$ 300,394
Income tax assessment from Danish Tax Authority	$ 103,050		$ 103,050

XML

Income Taxes

9 Months Ended

Sep. 30, 2011

Income Taxes [Abstract]

Income Taxes

(10) Income Taxes

The Company's effective tax rate for the three months ended September 30, 2011 and September 30, 2010 was 33.5% and 30.5%, respectively. The Company's effective tax rate for the nine months ended September 30, 2011 and September 30, 2010 was 33.4% and 31.9%, respectively. The Company's effective income tax rate for the three and nine months ended September 30, 2011 and 2010 differed from the federal statutory rate of 35.0% principally because of certain foreign tax rate differentials, state and local income taxes, foreign income currently taxable in the U.S., the production activities deduction and certain other permanent differences.

The Company has not provided for U.S. federal and/or state income and foreign withholding taxes on $300,394 of undistributed earnings from non-U.S. operations as of September 30, 2011 because Tempur-Pedic International intends to reinvest such earnings indefinitely outside of the United States.  If these earnings were to be distributed, foreign tax credits may become available under current law to reduce the resulting U.S. income tax liability.

During the fourth quarter of 2007, the Company received an income tax assessment from the Danish Tax Authority with respect to the 2001, 2002 and 2003 tax years, an assessment with respect to the 2004 tax year during the third quarter of 2010, and an assessment with respect to the 2005 tax year during the second quarter of 2011.  The tax assessments relate to the royalty paid by one of Tempur-Pedic International's U.S. subsidiaries to a Danish subsidiary and the position taken by the Danish Tax Authority could apply to subsequent years. The total tax assessment is approximately $103,050 including interest and penalties.  In the first quarter of 2008 and the third quarter of 2010, the Company filed timely complaints with the Danish National Tax Tribunal denying the tax assessments.  The National Tax Tribunal formally agreed to place the Danish tax litigation on hold pending the outcome of a Bilateral Advance Pricing Agreement (Bilateral APA) between the United States and the Danish Tax Authority.  A Bilateral APA involves an agreement between the Internal Revenue Service (IRS) and the taxpayer, as well as a negotiated agreement with one or more foreign competent authorities under applicable income tax treaties.  During the third quarter of 2008, the Company filed the Bilateral APA with the IRS and the Danish Tax Authority.  U.S. and Danish competent authorities initially met to discuss the Company's Bilateral APA during the first quarter of 2011 and additional meetings are expected. The Company believes it has meritorious defenses to the proposed adjustments and will oppose the assessments in the Danish courts, as necessary. It is reasonably possible the amount of unrecognized tax benefits may change in the next twelve months.  An estimate of the amount of such change cannot be made at this time.

                The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, and various states and foreign jurisdictions.  With few exceptions, the Company is no longer subject to tax examinations by tax authorities in the U.S. for periods prior to 2007, U.S. state and local municipalities for periods prior to 2006, and in non-U.S. jurisdictions for periods prior to 2003. Additionally, the Company is currently under examination by various tax authorities around the world.  The Company anticipates it is reasonably possible an increase or decrease in the amount of unrecognized tax benefits could be made in the next twelve months as a result of the statute of limitations expiring and/or the examinations being concluded on these returns.  However, the Company does not presently anticipate that any increase or decrease in unrecognized tax benefits will be material to the consolidated financial statements. During the three months ended September 30, 2011, there were no significant changes to the liability for unrecognized tax benefits.

XML

Goodwill and Other intangible assets (Tables)

9 Months Ended

Sep. 30, 2011

Goodwill and Other intangible assets [Abstract]

Goodwill by Business Segment

The following summarizes changes to the Company's Goodwill, by reportable business segment:

	North America			International			Total
Balance as of December 31, 2010	$	108,931		$	103,537		$	212,468
Foreign currency translation adjustments		(912	)		(125	)		(1,037	)
Goodwill resulting from acquisition		-			1,337			1,337
Balance as of September 30, 2011	$	108,019		$	104,749		$	212,768

Other Intangible Assets

The following table summarizes information relating to the Company's Other intangible assets, net:

		September 30, 2011						December 31, 2010
	Useful	Gross				Net			Gross				Net
	Lives	Carrying		Accumulated		Carrying			Carrying		Accumulated		Carrying
	(Years)	Amount		Amortization		Amount			Amount		Amortization		Amount
Unamortized indefinite life intangible assets:
Trademarks		$	55,000	$	-	$	55,000	$	55,000	$	-	$	55,000
Amortized intangible assets:
Technology	10	$	16,000	$	14,267	$	1,733	$	16,000	$	13,067	$	2,933
Patents & othe trademarks	5-20		12,533		9,030		3,503		12,063		8,575		3,488
Customer database	5		4,815		4,784		31		4,813		4,691		122
Foam formula	10		3,700		3,299		401		3,700		3,022		678
Reacquired rights	3		5,490		2,745		2,745		5,767		1,440		4,327
Customer relationships	5		5,032		730		4,302		2,492		295		2,197
Total		$	102,570	$	34,855	$	67,715	$	99,835	$	31,090	$	68,745

XML

Earnings Per Common Share

9 Months Ended

Sep. 30, 2011

Earnings Per Common Share [Abstract]

Earnings Per Common Share

(11) Earnings Per Common Share

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Numerator:
Net income	$	61,949	$	44,198	$	163,293	$	110,852
Denominator:
Denominator for basic earnings per common share-weighted average shares		66,655		69,199		67,722		71,065
Effect of dilutive securities:
Employee stock-based compensation		1,916		2,234		2,125		2,385
Denominator for diluted earnings per common share-adjusted weighted average shares		68,571		71,433		69,847		73,450
Basic earnings per common share	$	0.93	$	0.64	$	2.41	$	1.56
Diluted earnings per common share	$	0.90	$	0.62	$	2.34	$	1.51

The Company excluded 8 and 173 shares issuable upon exercise of outstanding stock options for the three months ended September 30, 2011 and 2010, respectively, and 4 and 120 shares issuable upon exercise of outstanding stock options for the nine month periods ended September 30, 2011 and 2010, respectively, from the Diluted earnings per common share computation because their exercise price was greater than the average market price of Tempur-Pedic International's common stock or they were otherwise anti-dilutive.

XML

Stockholders' Equity (Details) In Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2011 USD ($)	Dec. 31, 2010 USD ($)	Sep. 30, 2011	Jul. 25, 2011 USD ($)
Stockholders' Equity [Abstract]
Authorized shares of common stock (in shares)			300,000
Authorized shares of preferred stock (in shares)			10,000
Shares of common stock purchased (in shares)	4,251	8,500
Value of common stock repurchased	$ 240,000	$ 250,000
Value of common stock authorized by the board of directors				200,000
Remaining July 2011 authorization	$ 120,010

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2011

Commitments and Contingencies [Abstract]

Commitments and Contingencies

(9) Commitments and Contingencies

(a)Purchase Commitments. The Company enters into limited purchase commitments for the purchase of certain raw materials. Amounts committed under these programs were not significant as of September 30, 2011 or December 31, 2010.

(b) Antitrust Action. On January 5, 2007, a purported class action was filed against the Company in the United States District Court for the Northern District of Georgia, Rome Division (Jacobs v. Tempur-Pedic International, Inc. and Tempur-Pedic North America, Inc., or the Antitrust Action).  The Antitrust Action alleges violations of federal antitrust law arising from the pricing of Tempur-Pedic mattress products by Tempur-Pedic North America and certain distributors.  The action alleges a class of all purchasers of Tempur-Pedic mattresses in the United States since January 5, 2003, and seeks damages and injunctive relief. Count Two of the complaint was dismissed by the court on June 25, 2007, based on a motion filed by the Company. Following a decision issued by the United States Supreme Court in Leegin Creative Leather Prods., Inc. v. PSKS, Inc. on June 28, 2007, the Company filed a motion to dismiss the remaining two counts of the Antitrust Action on July 10, 2007. On December 11, 2007, that motion was granted and, as a result, judgment was entered in favor of the Company and the plaintiffs' complaint was dismissed with prejudice. On December 21, 2007, the plaintiffs filed a “Motion to Alter or Amend Judgment,” which was fully briefed. On May 1, 2008, that motion was denied.  Jacobs appealed the dismissal of their claims, and the parties argued the appeal before the United States Circuit Court for the Eleventh Circuit on December 11, 2008.  The Court rendered an opinion favorable to the Company on December 2, 2010, affirming the trial court's refusal to allow Jacobs to alter or amend its pleadings and dismissing its claims.  Jacobs has subsequently petitioned the 11th Circuit Court of Appeals for an “en banc” review of the three judge panel's ruling.  The Company continues to strongly believe that the Antitrust Action lacks merit, and intends to defend against the claims vigorously. Based on the findings of the court to date and an assessment of the Company's meritorious defenses, the Company believes that it is remote that it will incur a loss with respect to this matter. However, due to the inherent uncertainties of litigation, the Company cannot predict the outcome of the Antitrust Action at this time, and can give no assurance that these claims will not have a material adverse affect on the Company's financial position or results of operations.

(c) New York Attorney General. In December 2008, the Office of the Attorney General of the State of New York, Antitrust Bureau (OAG) requested that the Company consider discontinuing its unilateral retail price policy (UPPL) in the State of New York, and informed the Company that it may bring an enforcement action against the Company under New York law if the Company chose not to do so. On March 29, 2010, the Office of the Attorney General filed suit in New York state court against the Company with respect to this matter. The complaint does not charge the Company with any violation of state or federal antitrust law; instead it claims the Company violated a 1975 New York state law which declares certain contractual provisions to be unenforceable and not actionable at law and seeks, among other things, a permanent injunction prohibiting the Company's UPPL as well as unspecified sums for restitution and disgorgement of profits. The Company responded to the complaint and also filed motions to dismiss and to obtain discovery. On September 28, 2010, the court heard various motions filed by the parties and took them under advisement. On January 14, 2011, the court denied the OAG's petition in full and granted the Company's motion to dismiss. The OAG filed an appeal on February 22, 2011. The Company believes that its UPPL complies with state and federal law and intends to continue to vigorously defend it in this matter. No claim for damages has been received by the Company. Based on the findings of the court to date and an assessment of the Company's meritorious defenses, the Company believes that it is remote that it will incur a loss with respect to this matter. However, due to the inherent uncertainties of litigation, the Company cannot predict the outcome of this matter at this time, and can give no assurance that these claims will not have a material adverse affect on the Company's financial position or results of operations.

The Company is involved in various other legal proceedings incidental to the operations of its business. The Company believes that the outcome of all such pending legal proceedings in the aggregate will not have a material adverse affect on its business, financial condition, liquidity, or operating results.

XML

Goodwill and Other intangible assets

9 Months Ended

Sep. 30, 2011

Goodwill and Other intangible assets [Abstract]

Goodwill and Other intangible assets

(2) Goodwill and Other intangible assets

The following summarizes changes to the Company's Goodwill, by reportable business segment:

	North America			International			Total
Balance as of December 31, 2010	$	108,931		$	103,537		$	212,468
Foreign currency translation adjustments		(912	)		(125	)		(1,037	)
Goodwill resulting from acquisition		-			1,337			1,337
Balance as of September 30, 2011	$	108,019		$	104,749		$	212,768

On July 4, 2011, the Company acquired the business of its third party distributor in South Korea. The Company paid $4,566 in cash to acquire this entity with additional future payments to former owners required based on certain financial and operational targets. Assets acquired include certain Intangible assets, Inventories, Property, plant and equipment, and Prepaids and other current assets, with the remaining consideration allocated to Goodwill.

 The following table summarizes information relating to the Company's Other intangible assets, net:

		September 30, 2011						December 31, 2010
	Useful	Gross				Net			Gross				Net
	Lives	Carrying		Accumulated		Carrying			Carrying		Accumulated		Carrying
	(Years)	Amount		Amortization		Amount			Amount		Amortization		Amount
Unamortized indefinite life intangible assets:
Trademarks		$	55,000	$	-	$	55,000	$	55,000	$	-	$	55,000
Amortized intangible assets:
Technology	10	$	16,000	$	14,267	$	1,733	$	16,000	$	13,067	$	2,933
Patents & othe trademarks	5-20		12,533		9,030		3,503		12,063		8,575		3,488
Customer database	5		4,815		4,784		31		4,813		4,691		122
Foam formula	10		3,700		3,299		401		3,700		3,022		678
Reacquired rights	3		5,490		2,745		2,745		5,767		1,440		4,327
Customer relationships	5		5,032		730		4,302		2,492		295		2,197
Total		$	102,570	$	34,855	$	67,715	$	99,835	$	31,090	$	68,745

Amortization expense relating to intangible assets for the Company was $1,429 and $1,219 for the three months ended September 30, 2011 and 2010, respectively. For the nine months ended September 30, 2011 and 2010, amortization expense relating to intangible assets was $3,978 and $3,123, respectively. No impairments of goodwill or other intangible assets have adjusted the gross carrying amount of these assets in any historical period.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2011

Derivative Financial Instruments [Abstract]

Derivative Financial Instruments

(5) Derivative Financial Instruments

In the normal course of business, the Company is exposed to certain risks related to fluctuations in interest rates and foreign currency exchange rates. The Company uses various derivative contracts, primarily interest rate swaps and foreign currency exchange forward contracts, to manage risks from these market fluctuations. The financial instruments used by the Company are straight-forward, non-leveraged instruments. The counterparties to these financial instruments are financial institutions with strong credit ratings. The Company maintains control over the size of positions entered into with any one counterparty and regularly monitors the credit ratings of these institutions.

Interest Rate Risk

The Company is exposed to changes in interest rates on its Senior Credit Facility. In order to manage this risk, on August 8, 2011, the Company entered into a four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates. The Company designated this interest rate swap as a cash flow hedge of floating rate borrowings and expects the hedge to be highly effective in offsetting fluctuations in the designated interest payments resulting from changes in the benchmark interest rate. The gains and losses on the designated swap agreement will offset losses and gains on the transactions being hedged. The Company formally documented the effectiveness of this qualifying hedge instrument (both at the inception of the swap and on an ongoing basis) in offsetting changes in cash flows of the hedged transaction. The fair value of the interest rate swap is calculated as described in Note 4, “Fair Value Measurements” taking into consideration current interest rates and the current creditworthiness of the counterparties or the Company, as applicable.

                As a result of this swap, the Company will pay interest at a fixed rate and receive payment at a variable rate beginning on December 30, 2011. The swap effectively fixes the floating LIBOR-based interest rate to 1.25% on $250,000 of the outstanding balance under the 2005 Senior Credit Facility, with the outstanding balance subject to the swap declining over time. The interest rate swap expires on December 30, 2015. The Company will select the LIBOR-based rate on the hedged portion of the Senior Credit Facility during the term of the swap. The effective portion of the change in value of the swap is reflected as a component of comprehensive income and recognized as Interest expense, net as payments are paid or accrued. The remaining gain or loss in excess of the cumulative change in the present value of the future cash flows of the hedged item, if any (i.e., the ineffective portion) or hedge components excluded from the assessment of effectiveness are recognized as Interest expense, net during the current period.

Foreign Currency Exposures

The Company is exposed to foreign currency risk related to intercompany debt and associated interest payments. To manage the risk associated with fluctuations in foreign currencies, the Company enters into foreign currency forward contracts. The Company does not designate any of these foreign currency forward contracts as hedging instruments, however, the Company considers the contracts as economic hedges. Accordingly, changes in the fair value of these instruments affect earnings during the current period. These foreign currency forward contracts protect against the reduction in value of forecasted foreign currency cash flows resulting from payments in foreign currencies. The fair value of foreign currency agreements are estimated as described in Note 4, “Fair Value Measurements” taking into consideration foreign currency rates and the current creditworthinessof the counterparties or the Company, as applicable.

As of September 30, 2011, the Company had foreign currency forward contracts with expiration dates ranging from October 28, 2011 through December 30, 2011. The changes in fair value of these foreign currency hedges are included as a component of Other expense, net. As of September 30, 2011, the Company had the following outstanding foreign currency forward contracts:

Foreign Currency Denomination	Notional Amount
Japanese Yen	¥	340,862
Swedish Krone	kr.	19,135
Norwegian Krone	kr.	7,108
Australian Dollar	$	1,727
New Zealand Dollar	$	1,954
Singapore Dollar	$	403
Canadian Dollar	$	523
United States Dollar	$	9,738

As of September 30, 2011 and December 31, 2010, the fair value carrying amount of the Company's derivative instruments included in the accompanying Condensed Consolidated Balance Sheets were recorded as follows:

		Liability Derivatives
		September 30, 2011			December 31, 2010
		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
	Interest rate swap – current	Accrued expenses and other current liabilities	$	1,050	Accrued expenses and other current liabilities	$	1,430
	Interest rate swap – non-current	Other non-current liabilities		1,268			-
			$	2,318		$	1,430
Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Accrued expenses and other current liabilities	$	622	Accrued expenses and other current liabilities	$	676
			$	2,940		$	2,106

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the three months ended September 30, 2011 was as follows:

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,266	)

For the three months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	1,280	Interest expense, net	$	(1,734	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	38

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the nine months ended September 30, 2011 was as follows:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)			Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Loss  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Loss  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	(582	)	Interest expense, net	$	(582	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(228	)

For the nine months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss) Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	4,003	Interest expense, net	$	(5,222	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,315	)

XML

Derivative Financial Instruments (Details) In Thousands	9 Months Ended																	3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended
	Sep. 30, 2011 USD ($)	Sep. 30, 2011 SEK	Sep. 30, 2011 NZD	Sep. 30, 2011 SGD	Sep. 30, 2011 CAD	Sep. 30, 2011 AUD	Sep. 30, 2011 NOK	Sep. 30, 2011 JPY (¥)	Dec. 31, 2010 USD ($)	Sep. 30, 2011 Designated as Hedging Instrument [Member] USD ($)	Dec. 31, 2010 Designated as Hedging Instrument [Member] USD ($)	Sep. 30, 2011 Designated as Hedging Instrument [Member] Interest Rate Swap [Member] Accrued expenses and other current liabilities [Member] USD ($)	Dec. 31, 2010 Designated as Hedging Instrument [Member] Interest Rate Swap [Member] Accrued expenses and other current liabilities [Member] USD ($)	Sep. 30, 2011 Designated as Hedging Instrument [Member] Interest Rate Swap [Member] Other Long Term Liabilities [Member] USD ($)	Dec. 31, 2010 Designated as Hedging Instrument [Member] Interest Rate Swap [Member] Other Long Term Liabilities [Member] USD ($)	Sep. 30, 2011 Not Designated as Hedging Instrument [Member] Foreign Exchange Forward [Member] Accrued expenses and other current liabilities [Member] USD ($)	Dec. 31, 2010 Not Designated as Hedging Instrument [Member] Foreign Exchange Forward [Member] Accrued expenses and other current liabilities [Member] USD ($)	Sep. 30, 2011 Foreign Exchange Forward [Member] Not Designated as Hedging Instrument [Member] Other Expense [Member] USD ($)	Sep. 30, 2010 Foreign Exchange Forward [Member] Not Designated as Hedging Instrument [Member] Other Expense [Member] USD ($)	Sep. 30, 2011 Foreign Exchange Forward [Member] Not Designated as Hedging Instrument [Member] Other Expense [Member] USD ($)	Sep. 30, 2010 Foreign Exchange Forward [Member] Not Designated as Hedging Instrument [Member] Other Expense [Member] USD ($)	Sep. 30, 2010 Interest Rate Swap [Member] Cash Flow Hedging [Member] Interest Expense [Member] USD ($)	Sep. 30, 2011 Interest Rate Swap [Member] Cash Flow Hedging [Member] Interest Expense [Member] USD ($)	Sep. 30, 2010 Interest Rate Swap [Member] Cash Flow Hedging [Member] Interest Expense [Member] USD ($)
Derivative Financial Instruments [Abstract]
LIBOR-based interest rate	LIBOR-based interest rate to 1.25
Senior Credit Facility balance covered under interest rate swap contracts	$ 250,000
Japanese Yen								340,862
Swedish Krone		19,135
Norwegian Krone							7,108
Australian Dollar						1,727
New Zealand Dollar			1,954
Singapore Dollar				403
Canadian Dollar					523
United States Dollar	9,738
Derivatives, Fair Value [Line Items]
Fair value of Derivative Liability	2,940								2,106	2,318	1,430	1,050	1,430	1,268	0	622	676
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Accumulated OCI on Derivative (Effective Portion)																						1,280	(582)	4,003
Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion)																						(1,734)	(582)	(5,222)
Amount of Gain/(Loss) Recognized in Income on Derivative																		$ (1,266)	$ 38	$ (228)	$ (1,315)	$ 0	$ 0	$ 0

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2011

Stockholders' Equity [Abstract]

Stockholders' Equity

(6) Stockholders' Equity

(a) Capital Stock. Tempur-Pedic International's authorized shares of capital stock are 300,000 shares of common stock and 10,000 shares of preferred stock. Subject to preferences that may be applicable to any outstanding preferred stock, holders of the common stock are entitled to receive ratably such dividends as may be declared from time to time by the Board of Directors out of funds legally available for that purpose. In the event of liquidation, dissolution or winding up, the holders of the common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding.

(b) Share Repurchase Programs. During the nine months ended September 30, 2011, the Company purchased 4,251 shares of the Company's common stock for a total of $240,000 pursuant to the authorizations adopted by the Company's Board of Directors in January and July 2011. During 2010, the Company purchased 8,500 shares of the Company's common stock for a total cost of $250,000 pursuant to the authorizations made by the Company's Board of Directors. On July 25, 2011, the Company's Board of Directors terminated the remaining authority under the January 2011 authorization and approved a new share repurchase authorization of up to $200,000 of the Company's common stock. As of September 30, 2011, the Company has $120,010 remaining under the July 2011 authorization. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under our credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice. Refer to Note 1(k), “Subsequent Events” for additional information regarding the Company's increase to the July 2011 authorization on October 18, 2011.

XML

Goodwill and Other intangible assets (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Jul. 04, 2011	Dec. 31, 2010
Goodwill [Line Items]
Balance at beginning of period			$ 212,468
Foreign currency translation adjustments			(1,037)
Goodwill resulting from acquisition			1,337
Balance at end of period	212,768		212,768
Paid in order to acquire this entity					4,566
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Gross Carrying Amount Total	102,570		102,570			99,835
Accumulated Amortization	34,855		34,855			31,090
Net Carrying Amount	67,715		67,715			68,745
Amortization expense relating to intangible assets	1,429	1,219	3,978	3,123
North America [Member]
Goodwill [Line Items]
Balance at beginning of period			108,931
Foreign currency translation adjustments			(912)
Goodwill resulting from acquisition			0
Balance at end of period	108,019		108,019
International [Member]
Goodwill [Line Items]
Balance at beginning of period			103,537
Foreign currency translation adjustments			(125)
Goodwill resulting from acquisition			1,337
Balance at end of period	104,749		104,749
Trademarks [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Gross Carrying Amount - Indefinite Life Intangible Assets	55,000		55,000			55,000
Accumulated Amortization	0		0			0
Net Carrying Amount	55,000		55,000			55,000
Technology [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives (in years)			10
Gross Carrying Amount - Finite Life Intangible Assets	16,000		16,000			16,000
Accumulated Amortization	14,267		14,267			13,067
Net Carrying Amount	1,733		1,733			2,933
Patents & Other Trademarks [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives - Minimum (in years)			5
Useful Lives - Maximum (in years)			20
Gross Carrying Amount - Finite Life Intangible Assets	12,533		12,533			12,063
Accumulated Amortization	9,030		9,030			8,575
Net Carrying Amount	3,503		3,503			3,488
Customer Lists [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives (in years)			5
Gross Carrying Amount - Finite Life Intangible Assets	4,815		4,815			4,813
Accumulated Amortization	4,784		4,784			4,691
Net Carrying Amount	31		31			122
Foam Formula [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives (in years)			10
Gross Carrying Amount - Finite Life Intangible Assets	3,700		3,700			3,700
Accumulated Amortization	3,299		3,299			3,022
Net Carrying Amount	401		401			678
Reacquired Rights [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives (in years)			3
Gross Carrying Amount - Finite Life Intangible Assets	5,490		5,490			5,767
Accumulated Amortization	2,745		2,745			1,440
Net Carrying Amount	2,745		2,745			4,327
Customer Relationships [Member]
Intangible Assets, Combined Indefinite-lived and Finite-lived Intangible Assets by Major Class [Line Items]
Useful Lives (in years)			5
Gross Carrying Amount - Finite Life Intangible Assets	5,032		5,032			2,492
Accumulated Amortization	730		730			295
Net Carrying Amount	$ 4,302		$ 4,302			$ 2,197

XML

Other Items (Details) (USD $) In Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Property, plant and equipment, net [Abstract]
Land and buildings	$ 122,690		$ 122,690		$ 121,188
Machinery and equipment, furniture and fixtures and other	225,218		225,218		208,310
Construction in progress	9,834		9,834		9,858
Total property, plant and equipment	357,742		357,742		339,356
Accumulated depreciation	(199,175)		(199,175)		(179,549)
Net property, plant and equipment	158,567		158,567		159,807
Accrued Expenses And Other Current Liabilities Components [Abstract]
Salary and related expenses	20,996		20,996		22,171
Accrued unrecognized tax benefits	12,398		12,398		12,035
Advertising accrual	10,443		10,443		6,981
Accrued sales and value added taxes	9,881		9,881		10,614
Warranty accrual	4,730		4,730		4,081
Sales returns	4,925		4,925		4,402
Other	26,083		26,083		25,185
Total accrued expenses and other current liabilites	89,456		89,456		85,469
Accumulated other comprehensive income (loss) [Abstract]
Derivative instruments accounted for as hedges, net of taxes	(1,414)		(1,414)		(872)
Foreign currency translation adjustments	(8,174)		(8,174)		(5,316)
Accumulated other comprehensive loss	(9,588)		(9,588)		(6,188)
Comprehensive income [Abstract]
Net income	61,949	44,198	163,293	110,852
Derivative instruments accounted for as hedges, net of taxes of $904, $499, $346 and $1,561, respectively	(1,414)	781	(542)	2,442
Foreign currency adjustments	(14,344)	11,744	(2,858)	(1,472)
Total comprehensive income	46,191	56,723	159,893	111,822
Derivative instruments accounted for as hedges, net of taxes			904		558
Derivative instruments accounted for as hedges, net of taxes	$ 904	$ 499	$ 346	$ 1,561

XML

Fair Value Measurements (Details) (USD $) In Thousands	Sep. 30, 2011	Dec. 31, 2010
Estimate of Fair Value, Fair Value Disclosure [Member]
Liabilities: [Abstract]
Foreign currency forward contracts	$ 622	$ 676
Interest Rate Swap	2,318	1,430
Fair Value, Inputs, Level 1 [Member]
Liabilities: [Abstract]
Foreign currency forward contracts	0	0
Interest Rate Swap	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities: [Abstract]
Foreign currency forward contracts	622	676
Interest Rate Swap	2,318	1,430
Fair Value, Inputs, Level 3 [Member]
Liabilities: [Abstract]
Foreign currency forward contracts	0	0
Interest Rate Swap	$ 0	$ 0

XML

Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2011

Accounting Policies [Abstract]

Inventories Table

Inventories are stated at the lower of cost or market, determined by the first-in, first-out method, and consist of the following:

	September 30, 2011		December 31, 2010
Finished goods	$	66,354	$	53,362
Work-in-process		9,603		5,549
Raw materials and supplies		15,089		10,945
	$	91,046	$	69,856

Changes In Accrued Sales Returns

The Company had the following activity for sales returns from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,402
Amounts accrued		36,979
Returns charged to accrual		(36,456	)
Balance as of September 30, 2011	$	4,925

Warranty Activity

The Company had the following activity for warranties from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,081
Amounts accrued		4,012
Warranties charged to accrual		(3,363	)
Balance as of September 30, 2011	$	4,730

XML

Other Items

9 Months Ended

Sep. 30, 2011

Disclosure Text Block Supplement [Abstract]

Other Items

(7) Other Items

(a) Property, plant and equipment.  Property, plant and equipment, net consisted of the following:

	September 30, 2011			December 31, 2010
Land and buildings	$	122,690		$	121,188
Machinery and equipment, furniture and fixtures and other		225,218			208,310
Construction in progress		9,834			9,858
		357,742			339,356
Accumulated depreciation		(199,175	)		(179,549	)
	$	158,567		$	159,807

(b) Accrued expenses and other current liabilities. Accrued expenses and other current liabilities consisted of the following:

	September 30,2011		December 31, 2010
Salary and related expenses	$	20,996	$	22,171
Accrued unrecognized tax benefits		12,398		12,035
Advertising accrual		10,443		6,981
Accrued sales and value added taxes		9,881		10,614
Warranty accrual		4,730		4,081
Sales returns		4,925		4,402
Other		26,083		25,185
	$	89,456	$	85,469

(c) Accumulated other comprehensive loss. Accumulated other comprehensive loss consisted of the following:

	September 30, 2011			December 31, 2010
Derivative instruments accounted for as hedges, net of taxes of $904 and $558, respectively	$	(1,414	)	$	(872	)
Foreign currency adjustments		(8,174	)		(5,316	)
Accumulated other comprehensive loss	$	(9,588	)	$	(6,188	)

(d) Comprehensive income. The components of comprehensive income consisted of the following:

	Three Months Ended September 30,					Nine Months Ended September 30,
	2011			2010		2011			2010
Net income	$	61,949		$	44,198	$	163,293		$	110,852
Derivative instruments accounted for as hedges, net of taxes of $904, $499, $346 and $1,561, respectively		(1,414	)		781		(542	)		2,442
Foreign currency adjustments		(14,344	)		11,744		(2,858	)		(1,472	)
Total comprehensive income	$	46,191		$	56,723	$	159,893		$	111,822

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2011

Fair Value Measurements [Abstract]

Fair Value Measurements

The following table provides a summary by level of the fair value of financial instruments that are measured on a recurring basis:

			Fair Value Measurements at September 30, 2011 Using:
	September 30, 2011		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	622	$	-	$	622	$	-
Interest rate swap	$	2,318	$	-	$	2,318	$	-

			Fair Value Measurements at December 31, 2010 Using:
	December 31, 2010		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Foreign currency forward contracts	$	676	$	-	$	676	$	-
Interest rate swap	$	1,430	$	-	$	1,430	$	-

XML

Long-term Debt (Details) In Thousands, unless otherwise specified			9 Months Ended				9 Months Ended
	Sep. 30, 2011 USD ($)	Dec. 31, 2010 USD ($)	Sep. 30, 2011 Letter of Credit [Member] USD ($)	Sep. 30, 2010 Letter of Credit [Member]	Dec. 31, 2010 Letter of Credit [Member] USD ($)	Sep. 30, 2011 Domestic Line Of Credit [Member] USD ($)	Sep. 30, 2011 Foreign Line of Credit [Member] USD ($)
Line of Credit Facility [Line Items]
Long-term debt, revolving credit facility	$ 508,500	$ 407,000	$ 508,500		$ 407,000
Index Rate or LIBOR plus (in hundredths)	1.99%	1.87%
Line of Credit Facility, Initiation Date			2005-10-18
Line of Credit Facility, expiration date			2016-06-28
Principal borrowing capacity, maximum			770,000			745,000	25,000
Option to increase domestic availability			250,000
Revolving credit facility period (in years)			5 Y				5 Y
Aggregate amount of Contingent Liabilities outstanding			990
Remaining borrowing capacity			260,510
Interest rate description			The base rate of U.S. dollar-denominated loans is defined as the higher of the Bank of America prime rate or the Federal Funds rate plus 50%
Credit facility commitment fee, minimum (in hundredths)			0.375%
Credit facility commitment fee, maximum (in hundredths)			0.50%
Compliance with covenants			The Company was in compliance with all covenants as of September 30, 2011.
Deferred financing costs			$ 6,192
Deferred financing costs amortization period (in years)				5 Y
Interest rate swap period agreement (in years)				4 Y

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2011

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

(1) Summary of Significant Accounting Policies

(a) Basis of Presentation and Description of Business. Tempur-Pedic International Inc., a Delaware corporation, together with its subsidiaries is a U.S. based, multinational company. The term “Tempur-Pedic International” refers to Tempur-Pedic International Inc. only, and the term “Company” refers to Tempur-Pedic International Inc. and its consolidated subsidiaries.

The Company manufactures, markets and sells products including pillows, mattresses and other related products. The Company manufactures essentially all its pressure-relieving TEMPUR® products at three manufacturing facilities, with one located in Denmark and two in the U.S. The Company has sales distribution subsidiaries operating in North America, Europe and Asia Pacific and has third party distribution arrangements in certain other countries where it does not have subsidiaries. The Company sells its products through four sales channels: Retail, Direct, Healthcare and Third party.

                The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States (U.S. GAAP) for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the

consolidated financial statements of the Company and related footnotes for the year ended December 31, 2010, included in the Company's Annual Report on Form 10-K.

                The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein.

(b) Reclassifications. Certain prior period amounts have been reclassified to conform to the 2011 presentation of Condensed Consolidated Financial Statements, including a reclassification between current Deferred income tax assets and Prepaid expenses and other current assets. Additionally, during the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Income attributable to the noncontrolling interest was not material in 2010 and is presented within Other expense, net in the Condensed Consolidated Statements of Income. These changes do not materially impact previously reported subtotals within the Condensed Consolidated Financial Statements for any previous period presented.

(c) Basis of Consolidation. The accompanying Condensed Consolidated Financial Statements include the accounts of Tempur-Pedic International and its subsidiaries. All subsidiaries are wholly-owned. During the fourth quarter of 2010, the Company purchased its noncontrolling interest in Tempur Shanghai Holding Ltd. Intercompany balances and transactions have been eliminated.

(d) Use of Estimates. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company's results are affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies and changes in the prices of raw materials, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities and carries various levels of insurance, the Company could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings.

(e) Inventories. Inventories are stated at the lower of cost or market, determined by the first-in, first-out method, and consist of the following:

	September 30, 2011		December 31, 2010
Finished goods	$	66,354	$	53,362
Work-in-process		9,603		5,549
Raw materials and supplies		15,089		10,945
	$	91,046	$	69,856

(f)Accrued Sales Returns. The Company allows product returns up to 120 days following a sale through certain sales channels and on certain products. Estimated sales returns are provided at the time of sale based on historical sales channel return rates. The level of sales returns differs by channel with the Direct channel typically experiencing the highest rate of return.  Estimated future obligations related to these products are provided by a reduction of sales in the period in which the revenue is recognized. Accrued sales returns are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for sales returns from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,402
Amounts accrued		36,979
Returns charged to accrual		(36,456	)
Balance as of September 30, 2011	$	4,925

(g) Warranties. The Company provides a 20-year warranty for North American sales and a 15-year warranty for International sales on mattresses, each prorated for the last 10 years. The Company also provides a 2-year to 3-year warranty on pillows. Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized. Estimates of warranty expenses are based primarily on historical claim experience and product testing. Warranties are included in Accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets.

The Company had the following activity for warranties from December 31, 2010 to September 30, 2011:

Balance as of December 31, 2010	$	4,081
Amounts accrued		4,012
Warranties charged to accrual		(3,363	)
Balance as of September 30, 2011	$	4,730

(h) Revenue Recognition. Sales of products are recognized when persuasive evidence of an arrangement exists, products are shipped and title passes to customers and the risks and rewards of ownership are transferred, the sales price is fixed or determinable and collectability is reasonably assured. The Company extends volume discounts to certain customers and reflects these amounts as a reduction of sales. The Company also reports sales net of tax assessed by qualifying governmental authorities. The Company extends credit based on the creditworthiness of its customers. No collateral is required on sales made in the normal course of business.

The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing accounts receivable. The Company regularly reviews the adequacy of its allowance for doubtful accounts. The Company determines the allowance based on historical write-off experience and current economic conditions. It also considers factors such as customer credit, past transaction history with the customer and changes in customer payment terms when determining whether the collection of a receivable is reasonably assured. Account balances are charged off against the allowance after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts included in Accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets was $6,740 and $7,437 as of September 30, 2011 and December 31, 2010, respectively.

(i) Advertising Costs. The Company expenses advertising costs as incurred except for production costs and advance payments, which are deferred and expensed when advertisements run for the first time. Direct response advance payments are deferred and are amortized over the life of the program.

(j) Research and Development Expenses. Research and development expenses for new products are expensed as they are incurred and included in General, administrative and other expenses in the accompanying Condensed Consolidated Statements of Income. Research and development costs charged to expense were $2,373 and $1,714 for the three months ended September 30, 2011 and 2010, respectively. For the nine months ended September 30, 2011 and 2010, research and development costs charged to expense were $7,273 and $5,263, respectively.

(k) Subsequent Events. On October 18, 2011, the Company's Board of Directors approved the purchase of an additional $80,000 of the Company's common stock under the previously approved July 2011 authorization. After giving effect to this approval, the total amount authorized and available for repurchase of the Company's common stock under this authorization is $200,010. Share repurchases under this authorization may be made through open market transactions, negotiated purchases or otherwise, at times and in such amounts as management and a committee of the Board deem appropriate; these repurchases may be funded by operating cash flows and/or borrowings under the Company's credit facility. This share repurchase program may be limited, suspended or terminated at any time without notice.

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2011

Derivative Financial Instruments [Abstract]

Foreign Currency Denomination

As of September 30, 2011, the Company had the following outstanding foreign currency forward contracts:

Foreign Currency Denomination	Notional Amount
Japanese Yen	¥	340,862
Swedish Krone	kr.	19,135
Norwegian Krone	kr.	7,108
Australian Dollar	$	1,727
New Zealand Dollar	$	1,954
Singapore Dollar	$	403
Canadian Dollar	$	523
United States Dollar	$	9,738

Liability Derivatives

As of September 30, 2011 and December 31, 2010, the fair value carrying amount of the Company's derivative instruments included in the accompanying Condensed Consolidated Balance Sheets were recorded as follows:

		Liability Derivatives
		September 30, 2011			December 31, 2010
		Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Derivatives designated as hedging instruments
	Interest rate swap – current	Accrued expenses and other current liabilities	$	1,050	Accrued expenses and other current liabilities	$	1,430
	Interest rate swap – non-current	Other non-current liabilities		1,268			-
			$	2,318		$	1,430
Derivatives not designated as hedging instruments
	Foreign exchange forward contracts	Accrued expenses and other current liabilities	$	622	Accrued expenses and other current liabilities	$	676
			$	2,940		$	2,106

Effect of derivative instruments on Condensed Consolidated Statement of Income

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the three months ended September 30, 2011 was as follows:

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,266	)

For the three months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	1,280	Interest expense, net	$	(1,734	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	38

The effect of derivative instruments on the accompanying Condensed Consolidated Statements of Income for the nine months ended September 30, 2011 was as follows:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)			Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss)  Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Loss  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Loss  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	(582	)	Interest expense, net	$	(582	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(228	)

For the nine months ended September 30, 2010:

Derivatives Designated as Cash Flow Hedging Relationships	Amount of Gain/(Loss)  Recognized in Accumulated OCL on  Derivative  (Effective Portion)		Location of Gain/(Loss)  Reclassified from  Accumulated OCL into  Income  (Effective Portion)	Amount of Gain/(Loss) Reclassified from  Accumulated OCL  into Income  (Effective Portion)			Location of Gain/(Loss)  Recognized in Income on  Derivative (Ineffective  Portion and Amount  Excluded from  Effectiveness Testing)	Amount of Gain/(Loss)  Recognized in Income  on Derivative  (Ineffective Portion  and Amount Excluded  from Effectiveness Testing)
Interest rate swap	$	4,003	Interest expense, net	$	(5,222	)	Interest expense, net	$	-

Derivatives Not  Designated as Hedging Instruments	Location of Gain/(Loss)  Recognized in Income on  Derivative	Amount of Gain/(Loss)  Recognized in Income  on Derivative
Foreign exchange forward contracts	Other expense, net	$	(1,315	)

XML

Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2011

Stock-Based Compensation [Abstract]

Black-Scholes option pricing model using the following assumptions

The options granted in the three months ended September 30, 2011 had a weighted average grant-date fair value of $32.53 per option, as determined by the Black-Scholes option pricing model using the following assumptions:

Expected volatility of stock	73.34	%
Expected life of options, in years	4.0
Risk-free interest rate	0.66	%
Expected dividend yield on stock	0.0	%

XML

Long-term Debt

9 Months Ended

Sep. 30, 2011

Long-term Debt [Abstract]

Long-term Debt

(3) Long-term Debt

(a) Long-term Debt. Long-term debt for the Company consists of the following:

	September 30, 2011		December 31, 2010
Senior Credit Facility:
Domestic Long-Term Revolving Criedit Facility payable to lenders, interest at Base Rate or LIBOR plus applicable margin (1.99% and 1.87% as of
September 30, 2011 and December 31, 2010, respectively), commitment through and due June 28, 2016	$	508,500	$	407,000
Long-term debt	$	508,500	$	407,000

                (b)Secured Credit Financing. On October 18, 2005, the Company entered into a credit agreement (Senior Credit Facility) with a syndicate of banks. On June 28, 2011, the Company amended and restated its Senior Credit Facility, as amended, which increased the total availability under the Senior Credit Facility to an aggregate of $770,000, added an option to increase domestic availability by an additional $250,000, extended the maturity date to June 28, 2016, and increased the applicable margins and certain fees to current market conditions.

The Senior Credit Facility consists of domestic and foreign credit facilities (Revolvers) that provide for the incurrence of indebtedness up to an aggregate principal amount of $770,000. The domestic credit facility is a five-year, $745,000 revolving credit facility. The foreign credit facility is a five-year, $25,000 revolving credit facility. The Revolvers provide for the issuance of letters of credit and bank guarantees (Contingent Liabilities) which, when issued, constitute usage and reduce availability under the Revolvers. The aggregate amount of Contingent Liabilities outstanding under the Revolvers was $990 at September 30, 2011. After giving effect to Contingent Liabilities and $508,500 in borrowings under the Revolvers, total availability under the Revolvers was $260,510 as of September 30, 2011. Both credit facilities bear interest at a rate equal to the applicable margin, as determined in accordance with a performance pricing grid set forth in the Senior Credit Facility, plus one of the following indexes: London Inter-Bank Offering Rate (LIBOR) and for U.S. dollar-denominated loans only, a base rate. The base rate of U.S. dollar-denominated loans is defined as the higher of the Bank of America prime rate or the Federal Funds rate plus .50%. The Company also pays an annual commitment fee on the unused amount of the Senior Credit Facility.  The commitment fee is calculated based on the consolidated leverage ratio and ranges from .375% to .50%.

The Senior Credit Facility is guaranteed by Tempur-Pedic International, as well as certain other subsidiaries of Tempur-Pedic International, and is secured by certain fixed and intangible assets of Dan-Foam ApS and substantially all the Company's U.S. assets. The Senior Credit Facility contains certain financial covenants and requirements affecting the Company, including a consolidated interest coverage ratio and a consolidated leverage ratio. The Company was in compliance with all covenants as of September 30, 2011.

In conjunction with the Company amending and restating its Senior Credit Facility, $6,192 of deferred financing costs were capitalized and will be amortized over the five year extension.

On August 8, 2011, the Company entered into a four-year interest rate swap agreement to manage interest costs and the risk associated with changing interest rates associated with the Senior Credit Facility. Refer to Note 5, “Derivative Financial Instruments” for additional information regarding the Company's derivative instruments, including this interest rate swap.

XML

Business Segment Information

9 Months Ended

Sep. 30, 2011

Business Segment Information [Abstract]

Business Segment Information

(12) Business Segment Information

The Company operates in two business segments: North America and International. These reportable segments are strategic business units that are managed separately based on the fundamental differences in their operations. The North American segment consists of the two U.S. manufacturing facilities and our North American distribution subsidiaries. The International segment consists of the manufacturing facility in Denmark, whose customers include all of the distribution subsidiaries and third party distributors outside the North American segment. The Company evaluates segment performance based on Net sales and Operating income.

The following table summarizes Total assets by segment:

	September 30, 2011			December 31, 2010
Total assets:
North America	$	674,155		$	576,139
International		409,945			338,685
Intercompany eliminations		(255,464	)		(198,821	)
	$	828,636		$	716,003

 The following table summarizes segment information:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2011		2010		2011		2010
Net sales from external customers:
North America
Mattresses	$	192,683	$	150,941	$	527,398	$	405,013
Pillows		19,182		18,307		53,502		46,494
Other		67,462		45,439		174,542		121,955
	$	279,327	$	214,687	$	755,442	$	573,462
International
Mattresses	$	63,122	$	48,224	$	178,361	$	141,841
Pillows		18,937		15,652		54,215		46,136
Other		21,699		17,222		63,117		51,279
	$	103,758	$	81,098	$	295,693	$	239,256
	$	383,085	$	295,785	$	1,051,135	$	812,718
Inter-segment sales:
North America	$	2,465	$	169	$	2,778	$	169
International		864		634		2,092		1,295
Intercompany eliminations		(3,329)		(803)		(4,870)		(1,464)
	$	-	$	-	$	-	$	-
Gross Profit
Domestic	$	139,744	$	101,835	$	375,760	$	263,753
International		60,850		48,919		176,162		139,851
	$	200,594	$	150,754	$	551,922	$	403,604
Operating income:
North America	$	69,390	$	45,498	$	179,789	$	108,622
International		27,217		22,656		74,928		65,672
	$	96,607	$	68,154	$	254,717	$	174,294
Depreciation and amortization (including stock-based compensation amortization):
North America	$	9,255	$	8,545	$	28,516	$	25,148
International		2,911		2,233		7,959		6,675
	$	12,166	$	10,778	$	36,475	$	31,823
Capital expenditures:
North America	$	4,434	$	3,116	$	11,392	$	7,043
International		2,309		2,516		7,449		5,287
	$	6,743	$	5,632	$	18,841	$	12,330

XML

Stock-Based Compensation (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognized compensation expense	$ 3,416	$ 2,614	$ 11,135	$ 7,953
Expected volatility of stock (in hundredths)	73.34%
Expected life of options (in years)	4.0
Risk-free interest rate (in hundredths)	0.66%
Expected dividend yield on stock (in hundredths)	0.00%
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)			443	418
Unrecognized compensation expense	5,401		5,401
Unrecognized cost expected over weighted average remaining life (in years)			2.25
Recognized compensation expense	1,708	359	5,719	822
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)	2	30	85	192
Unrecognized compensation expense	1,609		1,609
Unrecognized cost expected over weighted average remaining life (in years)			2.27
Recognized compensation expense	1,237	1,720	3,931	5,892
Weighted average grant-date fair value per option (per share)			$ 32.53
Deferred Stock Units (DSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)			9
Unrecognized compensation expense	340		340
Unrecognized cost expected over weighted average remaining life (in years)			0.57
Restricted and Deferred Stock Units (RSUs) and DSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards granted (in shares)				188
Recognized compensation expense	$ 471	$ 535	$ 1,485	$ 1,224

XML

Long-term Debt (Tables)

9 Months Ended

Sep. 30, 2011

Long-term Debt [Abstract]

Senior credit facility

(a) Long-term Debt. Long-term debt for the Company consists of the following:

	September 30, 2011		December 31, 2010
Senior Credit Facility:
Domestic Long-Term Revolving Criedit Facility payable to lenders, interest at Base Rate or LIBOR plus applicable margin (1.99% and 1.87% as of  September 30, 2011 and December 31, 2010, respectively), commitment through and due June 28, 2016	$	508,500	$	407,000
Long-term debt	$	508,500	$	407,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) [Abstract]
Net sales	$ 383,085	$ 295,785	$ 1,051,135	$ 812,718
Cost of sales	182,491	145,031	499,213	409,114
Gross profit	200,594	150,754	551,922	403,604
Selling and marketing expenses	72,439	53,215	204,789	146,273
General, administrative and other expenses	31,548	29,385	92,416	83,037
Operating income	96,607	68,154	254,717	174,294
Other expense, net:
Interest expense, net	(3,265)	(4,068)	(8,450)	(11,043)
Other expense, net	(229)	(564)	(950)	(569)
Total other expense	(3,494)	(4,632)	(9,400)	(11,612)
Income before income taxes	93,113	63,522	245,317	162,682
Income tax provision	31,164	19,324	82,024	51,830
Net income	$ 61,949	$ 44,198	$ 163,293	$ 110,852
Earnings per common share:
Basic (in dollars per share)	$ 0.93	$ 0.64	$ 2.41	$ 1.56
Diluted (in dollars per share)	$ 0.90	$ 0.62	$ 2.34	$ 1.51
Weighted average common shares outstanding:
Basic (in shares)	66,655	69,199	67,722	71,065
Diluted (in shares)	68,571	71,433	69,847	73,450

XML

Earnings Per Common Share (Details) (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Numerator [Abstract]
Net income	$ 61,949	$ 44,198	$ 163,293	$ 110,852
Denominator [Abstract]
Denominator for basic earnings per common share-weighted average shares (in shares)	66,655	69,199	67,722	71,065
Effect of dilutive securities [Abstract]
Employee stock options (in shares)	1,916	2,234	2,125	2,385
Denominator for diluted earnings per common share-adjusted weighted average shares (in shares)	68,571	71,433	69,847	73,450
Basic earnings per common share (in dollars per share)	$ 0.93	$ 0.64	$ 2.41	$ 1.56
Diluted earnings per common share (in dollars per share)	$ 0.90	$ 0.62	$ 2.34	$ 1.51
Shares excluded from Diluted earning per common share computation as anti-dilutive (in shares)	8	173	4	120

XML

Business Segment Information (Details) (USD $) In Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Segment Reporting Information [Line Items]
Total assets	$ 828,636		$ 828,636		$ 716,003
Net sales from external customers	383,085	295,785	1,051,135	812,718
Inter-segment sales	0	0	0	0
Gross Profit	200,594	150,754	551,922	403,604
Operating income	96,607	68,154	254,717	174,294
Depreciation and amortization (including stock-based compensation amortization)	12,166	10,778	36,475	31,823
Capital expenditures	6,743	5,632	18,841	12,330
North America [Member]
Segment Reporting Information [Line Items]
Total assets	674,155		674,155		576,139
Net sales from external customers	279,327	214,687	755,442	573,462
Inter-segment sales	2,465	169	2,778	169
Gross Profit	139,744	101,835	375,760	263,753
Operating income	69,390	45,498	179,789	108,622
Depreciation and amortization (including stock-based compensation amortization)	9,255	8,545	28,516	25,148
Capital expenditures	4,434	3,116	11,392	7,043
North America [Member] | Mattresses [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	192,683	150,941	527,398	405,013
North America [Member] | Pillows [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	19,182	18,307	53,502	46,494
North America [Member] | Other Products [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	67,462	45,439	174,542	121,955
International [Member]
Segment Reporting Information [Line Items]
Total assets	409,945		409,945		338,685
Net sales from external customers	103,758	81,098	295,693	239,256
Inter-segment sales	864	634	2,092	1,295
Gross Profit	60,850	48,919	176,162	139,851
Operating income	27,217	22,656	74,928	65,672
Depreciation and amortization (including stock-based compensation amortization)	2,911	2,233	7,959	6,675
Capital expenditures	2,309	2,516	7,449	5,287
International [Member] | Mattresses [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	63,122	48,224	178,361	141,841
International [Member] | Pillows [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	18,937	15,652	54,215	46,136
International [Member] | Other Products [Member]
Segment Reporting Information [Line Items]
Net sales from external customers	21,699	17,222	63,117	51,279
Intersegment Elimination [Member]
Segment Reporting Information [Line Items]
Total assets	(255,464)		(255,464)		(198,821)
Inter-segment sales	$ (3,329)	$ (803)	$ (4,870)	$ (1,464)